TLR4基因转染树突状细胞对支气管哮喘的免疫调节作用
|
摘要
背景
支气管哮喘是一种慢性气道炎症性疾病,属于超敏反应性质,多种炎症细胞、炎症介质和细胞因子与其发生发展有关,其中辅助T细胞亚群(Th1/Th2)的失衡、Th2细胞数量增加、功能活化起着关键作用。树突状细胞是目前已知的功能最强的抗原递呈细胞(APC),系已知唯一能活化初始T细胞的APC,是识别内外源性抗原、调节天然免疫和获得性免疫的关键因素。已知分布于气道的DC是呼吸道免疫防御的前哨细胞,在通过胞饮、吞噬或受体介导的内吞三种方式摄取吸入性抗原后逐渐成熟,趋化因子、共刺激分子和MHCI工类分子表达增加,而FcγRII、FcγRI和FcεRI等表达减少,并于24小时内从气道迁移至纵隔淋巴结产生初级免疫应答,促使初始Th细胞(Th0)向Th1或Th2分化。Tho的活化需DC参与的抗原识别信号和协同刺激信号,其分化方向受控于抗原刺激后DC分泌的细胞因子,IL-12和IFN—γ是诱导Th0向Th1分化的重要细胞因子。许多试验显示DC的免疫调节作用与其细胞膜表面TLR的表达有关,一般认为相应P/NP通过TLR4激活DC主要引起IL-12p70、IFN-γ介导蛋白(IP-10)等细胞因子大量增加。鉴于树突状细胞TLR4对于T细胞分化的调节作用,若将TLR4基因通过腺病毒载体导入抗原(如LPS)激发的DC,可促使DC分泌较多的IFN-γ等,上调Th0表达的IL-12Rβ2和TLR4,从而利于Th0向Th1分化。
目的将转染了TLR4基因和LPS致敏的DC输入OVA诱导的过敏性哮喘模型小鼠体内,以促进Th1的分化,逆转过敏性哮喘的Th亚群失衡,从而通过TLR4基因转移DC干预的免疫调节方式探讨哮喘基因治疗的新方法。
方法
1.利用RT-PCR方法,从Balb/c小鼠脾组织细胞mRNA中扩增TLR4基因全长cDNA,并将其连接到pcDNA3.1(+)载体上,进行测序和核酸分析。
2.采用AdMax包装系统,将克隆了外源基因的腺病毒穿梭质粒与携带了腺病毒大部分基因组的包装质粒共转染293细胞,利用Cre/loxP系统的作用实现重组,产生重组腺病毒。RT-PCR方法检测AdV-TLR4mRNA在传代DC中的表达、Western Blot方法检测AdV-TLR4蛋白的表达。
3.RT-PCR方法检测AdV-TLR4转染的DCIL-12mRNA、IL-4mRNA和IFN-γmRNA表达的变化;ELISA方法检测AdV—TLR4转染的DC培养上清IL-12、IL-4和IFN-Y的表达水平;流式细胞仪分析AdV—TLR4转染的DC表面免疫特性标志蛋白Ia、CD40、CD80和CD 86的改变。
4.0.1%OVAAl(0H)_3溶液皮下注射、1%OVA的生理盐水溶液雾化吸入的方法制备小鼠哮喘模型;福尔马林组织固定、包埋、切片,HE染色和AB/PAS复染进行小鼠肺组织学形态观察,Gimsa-Wright染色观察BALF中Eos;骨髓细胞分离,红细胞裂解液处理,GM-CSF和IL-4诱导、RMPI1640完全培养基培养的方式获取DC,行哮喘小鼠DCTLR4mRNA和TLR4蛋白表达检测;ELISA方法检测小鼠脾细胞IL-4、IL-5、IFN-Y和血浆IgE含量、人血浆IL-4和IgE含量、BALF中IL-4和IgE含量;流式细胞仪方法检测脾细胞CD4+CD25+细胞百分比。
结果
1.扩增得到的小鼠TLR4基因cDNA全长2508bp,编码536个氨基酸,blast结果分析表明,该cDNA与Genbank中发表的序列(NM021297)具有100%的同源性。
2.重组质粒pDC316—mTLR4的PCR及酶切鉴定表明,TLR4基因被定向插入;与pBHGF35骨架质粒共转染293细胞并包装成病毒,经病毒DNA的PCR检测,证实已完成对重组病毒的包装;重组病毒转染小鼠DC,其TLR4mRNA和TLR4蛋白均明显表达。
3.诱导Th1细胞分化的IL-12、IFN-γ在Ad-TLR4转染DC后48小时表达量明显增高,而诱导Th2细胞分化的IL-4表达量明显降低;转染细胞的PCR检测显示IL-12 mRNA、IL-4 mRNA和IFN-Y mRNA的变化与相应蛋白表达量的变化具有一致性;LPS实验进一步证实显示,LPS对转染细胞表达细胞因子的影响与LPS有关,LPS(+)转染DC组上述细胞因子改变的幅度高于LPS(-)组,LPS具有促进和加强Ad-TLR4-DC的某些生物学特性的改变。流式细胞检测表明Ad5F35-mTLR4组DC细胞CD 86表达较对照组和Ad5F35一mCMV-EGFP明显增高;进一步的实验显示,Ad5F35-mTLR4转染DC LPS(+)组Ia、CD40和CD80表达较相应LPS(-)明显增高;LPS(+)对照组CD80和CD 86表达也较相应LPS(-)组明显增高。LPS具有促进和加强Ad-TLR4-DC细胞表面某些免疫特性标志蛋白的改变。
4.TLR4 DC悬液给予过敏性哮喘模型小鼠,显示表现为杯状细胞增生减少、气道内粘液减少,WBC数、Eso比率和IL-4水平均降低,而免疫调节性T细胞CD4+CD25+细胞百分率增高,显示TLR4 DC具有明显的抗支气管哮喘作用。TLR4 DC抗支气管哮喘的机制,推测与TLR4 DC激发使具有调节T细胞分化的细胞因子改变有关,如IFN-γ增加可促使Th1分化;TLR4DC进入机体还促使了免疫调节性T细胞CD4+CD25+增加,免疫调节性T细CD4+CD25+可增加机体对过敏物质的耐受性,进而可减轻其炎症反应。
结论
1.成功构建了小鼠TLR4基因的全长编码区cDNA。
2.重组病毒感染滴度为2.3×10~8 IU/ml,可用于体内外动物实验。在本研究中作为TLR4基因干预对机体Th1/Th2平衡影响的研究工具。
3.LPS促进Ad-TLR4-DC细胞表面Ia、CD40、CD80和CD 86免疫特性标志蛋白改变,促进DCIL-12、IL-4和IFN-γ表达改变,推测这些改变与DCTLR4信号传导有关。
4.TLR4 DC对OVA诱导的支气管炎症反应有一定抑制作用,LPS与TLR4有一定的协调作用,其机制与DC的免疫调节作用有关。
Background
Bronchial asthma(BA)refers to a chronic inflammatory disorder of the airways,resulting from mostly hypersensitivity.Its pathogenesis and development are considered related to diverse inflammatory cells, mediators and cell factors,and the imbalance of T cell subgroup (Th1/Th2),increase in Th2 cell number and its activated function may play a key role.Dendritic cell(DC)is up to now the most potent antigen presenting cell(APC)and is also the unique one to activate initial T cell, especially it is a critical factor to recognize exterior and interior antigen and regulate innate and adaptive immunity.DCs distributed in airways serve as the guard cells of respiratory system and turn mature after taking in inhaled antigen by pinocytosis,pahgocytosis and receptor-mediated endocytosis,manifested with increasing expression of chemotatic factors,costimulatory molecules and MHCII molecules, and decreasing expression of Fcγ～RII、FcγRI and Fcε1,which would move to mediastinal lymph node from airways within 24 hours to produce primary immune response,promoting initial Th cells(Th0)to transform into Th1 or Th2.The antigen recognition signal and costimulatory signal related to DC are necessary to Th0 activation because it is controlled by the cytokines produced by DCs stimulated by antigen.For example,IL-12 and IFN-γare key factors to induce Th0 into Th1.A great many studies indicated that DC's immune regulation was related to the expression of TLR on the surface of cell membrane. It is generally known that PAMP may activate DCs by TLR4,resulting in considerable secretion of cytokines such as IL-12p70 and IFN-γmediated protein(IP-10).In use of this mechanism,that is,TLR4 of DCs may promote the differentiation of T cells,we made a trial to induce gene TLR4 via adenovirus vector into DCs stimulated by antigen such as LPS,so that DCs could produce much more cytokines like IFN-γto up-regulate the expression of IL-12Rβ2 and TLR4 from Th0,which may induce Th0 into Th1.
Objective
We infused DCs(transfected by gene TLR4 and stimulated by LPS)into the mice with allergic asthma induced by OVA in order to promote the differentiation of Th1,and reverse the imbalance of T cell subgroup caused by allergic asthma.From this study,we expect to find a new gene therapy for asthma through intervention of DC transfected with TLR4.
Method
1.The full length cDNA of TLR4 gene was obtained by using RT-PCR method from mRNA of Balb/c mouse spleen cells and then was connected with pcDNA3.1(+)carrier for sequencing and nucleotide analysis.
2.With the aid of AdMax package system,293 cells were transfected with both adenovirus shuttle plasmid(with exogenous gene cloned)and packaging plasmid(with most adenovirus genomes),and then they were recombined via Cre/loxP system into recombinant adenovirus.AdV-TLR4 mRNA expression level in passage DCs was detected by RT-PCR assay and AdV-TLR4 protein level was detected by Western Blot method.
3.The expression of AdV-TLR4-transfected DCIL-12mRNA、IL-4mRNA and IFN-γmRNA were detected by RT-PCR;the expression of IL-12、IL-4 and IFN-γin culture supernatant of AdV-TLR4-transfected DCs were detected by ELISA assay;specific immunity marker proteins on the surface of AdV-TLR4-transfected DCs including Ia,CD40,CD80 and CD 86 were detected by flow cytometry.
4.Asthma mouse model was prepared with hypodermical injection of 0.1 %OVA Al(OH)3 solution and atomization of 1%OVA normal saline solution; tissue fixation with formalin,embedment,slice,HE stain and AB/PAS re-stain for mouse lung tissue morphologic observation.Eos in BALF was observed after Gimsa—Wright stain;the DCs were obtained through bone marrow cells separation,red blood cells treatement with lysate,induction of GM-CSF and IL-4,and RMPI 1640 culture,the expression level of both DCTLR4 mRNA and TLR4 protein of asthma mice were detected;IL-4、IL-5、IFN-γ,serum IgE level of mice spleen cells,human serum IL-4 and IgE,and IL-4 and IgE in BALF were detected via ELISA;CD4+ and CD25+ spleen cells percentage were detected with flow cytometry.
Result
1.Mouse TLR4 gene cDNA obtained from PCR has a full length of 2508bp and encodes 536 amino acids.The result of blast indicated this cDNA was 100%homologous with the one(sequence NO.NM021297)reported in Genbank.
2.PCR and enzyme digestion identification of recombinant plasmid showed:gene TLR4 was set correctly;pBHGF35 backbone plasmid was transfected into 293 cells and was packaged into virus.PCR assay proved the package of recombinant virus was finishend;the recombinant virus was transfected into mouse DCs and the TLR4 mRNA and TLR4 proteins were highly expressed.
3.1.L-12 and IFN-γ(inducing Th1 differentiation)were highly expressed 48 hours after DCs were transfected by Ad-TLR4,while,IL-4(inducing Th2 differentiation)showed a decreasing expression;PCR assay of transfected DC showed that the changes in IL-12 mRNA,IL-4 mRNA and IFN-γmRNA were consistent with the changes in corresponding proteins expression;LPS test indicated that LPS could effect the cytokines produced by transfected cells which were changed more greatly in LPS(+)group than that in LPS(-). LPS could also enhance some bionomics of Ad-TLR4-DC.2.Cytometry assay showed that CD86 was expressed more highly in Ad5F35-mTLR4 group than that in both control and Ad5F35-mCMV-EGFP group. Simultaneously,Ia,CD40 and CD80 of DC transfected by Ad5F35-mTLR4 were expressed much more highly in LPS(+)group than that in LPS(-)group; CD80 and CD86 in LPS(+)were more highly expressed than that in LPS(-) group.LPS may promote and strengthen the change of specific immunity marker proteins on the surface of Ad-TLR4-DCs.
4.When TLR4 DC suspension was given to the mice with allergic asthma,the result showed a decrease in beaker cell proliferation,mucosal fluid in airways,WBC,Eso ratio and IL-4 level.However the percentage of CD4+CD25+ cells increased,which indicating TLR4DC could resist bronchial asthma.The mechanism is possibly related to the cytokines induced by TLR4DCs and the former can promote T cells differentiation,for instance, IFN-γmay induce T11 differentiation;TLRC4DC may also increase immune-regulating T cells CD4+CD25+ that enhance the toleration of allergen and minimize the inflammation.
Conclusion
1.Full-length coding region cDNA of mouse TLR4 gene was successfully established.
2.Recombinant viral infection titer is 2.3×108 IU/ml and it can be utilized in animal experiment in vivo and in vitro.
3.LPS can lead to the change of specific immunity marker proteins on the surface of AdV-TLR4- DC including Ia,CD40,CD80 and CD 86,and it also result in the change of expression of IL-12,IL-4 and IFN-γsecreted by DC.These changes are presumed to be related to signal conduction of DCTLR4.
4.TLR4DC may inhibit the bronchial inflammation induced by OVA. Plus,LPS and TLR4 show a coordination which is possibly related to immune regulation of DC.
支气管哮喘是一种慢性气道炎症性疾病,属于超敏反应性质,多种炎症细胞、炎症介质和细胞因子与其发生发展有关,其中辅助T细胞亚群(Th1/Th2)的失衡、Th2细胞数量增加、功能活化起着关键作用。树突状细胞是目前已知的功能最强的抗原递呈细胞(APC),系已知唯一能活化初始T细胞的APC,是识别内外源性抗原、调节天然免疫和获得性免疫的关键因素。已知分布于气道的DC是呼吸道免疫防御的前哨细胞,在通过胞饮、吞噬或受体介导的内吞三种方式摄取吸入性抗原后逐渐成熟,趋化因子、共刺激分子和MHCI工类分子表达增加,而FcγRII、FcγRI和FcεRI等表达减少,并于24小时内从气道迁移至纵隔淋巴结产生初级免疫应答,促使初始Th细胞(Th0)向Th1或Th2分化。Tho的活化需DC参与的抗原识别信号和协同刺激信号,其分化方向受控于抗原刺激后DC分泌的细胞因子,IL-12和IFN—γ是诱导Th0向Th1分化的重要细胞因子。许多试验显示DC的免疫调节作用与其细胞膜表面TLR的表达有关,一般认为相应P/NP通过TLR4激活DC主要引起IL-12p70、IFN-γ介导蛋白(IP-10)等细胞因子大量增加。鉴于树突状细胞TLR4对于T细胞分化的调节作用,若将TLR4基因通过腺病毒载体导入抗原(如LPS)激发的DC,可促使DC分泌较多的IFN-γ等,上调Th0表达的IL-12Rβ2和TLR4,从而利于Th0向Th1分化。
目的将转染了TLR4基因和LPS致敏的DC输入OVA诱导的过敏性哮喘模型小鼠体内,以促进Th1的分化,逆转过敏性哮喘的Th亚群失衡,从而通过TLR4基因转移DC干预的免疫调节方式探讨哮喘基因治疗的新方法。
方法
1.利用RT-PCR方法,从Balb/c小鼠脾组织细胞mRNA中扩增TLR4基因全长cDNA,并将其连接到pcDNA3.1(+)载体上,进行测序和核酸分析。
2.采用AdMax包装系统,将克隆了外源基因的腺病毒穿梭质粒与携带了腺病毒大部分基因组的包装质粒共转染293细胞,利用Cre/loxP系统的作用实现重组,产生重组腺病毒。RT-PCR方法检测AdV-TLR4mRNA在传代DC中的表达、Western Blot方法检测AdV-TLR4蛋白的表达。
3.RT-PCR方法检测AdV-TLR4转染的DCIL-12mRNA、IL-4mRNA和IFN-γmRNA表达的变化;ELISA方法检测AdV—TLR4转染的DC培养上清IL-12、IL-4和IFN-Y的表达水平;流式细胞仪分析AdV—TLR4转染的DC表面免疫特性标志蛋白Ia、CD40、CD80和CD 86的改变。
4.0.1%OVAAl(0H)_3溶液皮下注射、1%OVA的生理盐水溶液雾化吸入的方法制备小鼠哮喘模型;福尔马林组织固定、包埋、切片,HE染色和AB/PAS复染进行小鼠肺组织学形态观察,Gimsa-Wright染色观察BALF中Eos;骨髓细胞分离,红细胞裂解液处理,GM-CSF和IL-4诱导、RMPI1640完全培养基培养的方式获取DC,行哮喘小鼠DCTLR4mRNA和TLR4蛋白表达检测;ELISA方法检测小鼠脾细胞IL-4、IL-5、IFN-Y和血浆IgE含量、人血浆IL-4和IgE含量、BALF中IL-4和IgE含量;流式细胞仪方法检测脾细胞CD4+CD25+细胞百分比。
结果
1.扩增得到的小鼠TLR4基因cDNA全长2508bp,编码536个氨基酸,blast结果分析表明,该cDNA与Genbank中发表的序列(NM021297)具有100%的同源性。
2.重组质粒pDC316—mTLR4的PCR及酶切鉴定表明,TLR4基因被定向插入;与pBHGF35骨架质粒共转染293细胞并包装成病毒,经病毒DNA的PCR检测,证实已完成对重组病毒的包装;重组病毒转染小鼠DC,其TLR4mRNA和TLR4蛋白均明显表达。
3.诱导Th1细胞分化的IL-12、IFN-γ在Ad-TLR4转染DC后48小时表达量明显增高,而诱导Th2细胞分化的IL-4表达量明显降低;转染细胞的PCR检测显示IL-12 mRNA、IL-4 mRNA和IFN-Y mRNA的变化与相应蛋白表达量的变化具有一致性;LPS实验进一步证实显示,LPS对转染细胞表达细胞因子的影响与LPS有关,LPS(+)转染DC组上述细胞因子改变的幅度高于LPS(-)组,LPS具有促进和加强Ad-TLR4-DC的某些生物学特性的改变。流式细胞检测表明Ad5F35-mTLR4组DC细胞CD 86表达较对照组和Ad5F35一mCMV-EGFP明显增高;进一步的实验显示,Ad5F35-mTLR4转染DC LPS(+)组Ia、CD40和CD80表达较相应LPS(-)明显增高;LPS(+)对照组CD80和CD 86表达也较相应LPS(-)组明显增高。LPS具有促进和加强Ad-TLR4-DC细胞表面某些免疫特性标志蛋白的改变。
4.TLR4 DC悬液给予过敏性哮喘模型小鼠,显示表现为杯状细胞增生减少、气道内粘液减少,WBC数、Eso比率和IL-4水平均降低,而免疫调节性T细胞CD4+CD25+细胞百分率增高,显示TLR4 DC具有明显的抗支气管哮喘作用。TLR4 DC抗支气管哮喘的机制,推测与TLR4 DC激发使具有调节T细胞分化的细胞因子改变有关,如IFN-γ增加可促使Th1分化;TLR4DC进入机体还促使了免疫调节性T细胞CD4+CD25+增加,免疫调节性T细CD4+CD25+可增加机体对过敏物质的耐受性,进而可减轻其炎症反应。
结论
1.成功构建了小鼠TLR4基因的全长编码区cDNA。
2.重组病毒感染滴度为2.3×10~8 IU/ml,可用于体内外动物实验。在本研究中作为TLR4基因干预对机体Th1/Th2平衡影响的研究工具。
3.LPS促进Ad-TLR4-DC细胞表面Ia、CD40、CD80和CD 86免疫特性标志蛋白改变,促进DCIL-12、IL-4和IFN-γ表达改变,推测这些改变与DCTLR4信号传导有关。
4.TLR4 DC对OVA诱导的支气管炎症反应有一定抑制作用,LPS与TLR4有一定的协调作用,其机制与DC的免疫调节作用有关。
Background
Bronchial asthma(BA)refers to a chronic inflammatory disorder of the airways,resulting from mostly hypersensitivity.Its pathogenesis and development are considered related to diverse inflammatory cells, mediators and cell factors,and the imbalance of T cell subgroup (Th1/Th2),increase in Th2 cell number and its activated function may play a key role.Dendritic cell(DC)is up to now the most potent antigen presenting cell(APC)and is also the unique one to activate initial T cell, especially it is a critical factor to recognize exterior and interior antigen and regulate innate and adaptive immunity.DCs distributed in airways serve as the guard cells of respiratory system and turn mature after taking in inhaled antigen by pinocytosis,pahgocytosis and receptor-mediated endocytosis,manifested with increasing expression of chemotatic factors,costimulatory molecules and MHCII molecules, and decreasing expression of Fcγ～RII、FcγRI and Fcε1,which would move to mediastinal lymph node from airways within 24 hours to produce primary immune response,promoting initial Th cells(Th0)to transform into Th1 or Th2.The antigen recognition signal and costimulatory signal related to DC are necessary to Th0 activation because it is controlled by the cytokines produced by DCs stimulated by antigen.For example,IL-12 and IFN-γare key factors to induce Th0 into Th1.A great many studies indicated that DC's immune regulation was related to the expression of TLR on the surface of cell membrane. It is generally known that PAMP may activate DCs by TLR4,resulting in considerable secretion of cytokines such as IL-12p70 and IFN-γmediated protein(IP-10).In use of this mechanism,that is,TLR4 of DCs may promote the differentiation of T cells,we made a trial to induce gene TLR4 via adenovirus vector into DCs stimulated by antigen such as LPS,so that DCs could produce much more cytokines like IFN-γto up-regulate the expression of IL-12Rβ2 and TLR4 from Th0,which may induce Th0 into Th1.
Objective
We infused DCs(transfected by gene TLR4 and stimulated by LPS)into the mice with allergic asthma induced by OVA in order to promote the differentiation of Th1,and reverse the imbalance of T cell subgroup caused by allergic asthma.From this study,we expect to find a new gene therapy for asthma through intervention of DC transfected with TLR4.
Method
1.The full length cDNA of TLR4 gene was obtained by using RT-PCR method from mRNA of Balb/c mouse spleen cells and then was connected with pcDNA3.1(+)carrier for sequencing and nucleotide analysis.
2.With the aid of AdMax package system,293 cells were transfected with both adenovirus shuttle plasmid(with exogenous gene cloned)and packaging plasmid(with most adenovirus genomes),and then they were recombined via Cre/loxP system into recombinant adenovirus.AdV-TLR4 mRNA expression level in passage DCs was detected by RT-PCR assay and AdV-TLR4 protein level was detected by Western Blot method.
3.The expression of AdV-TLR4-transfected DCIL-12mRNA、IL-4mRNA and IFN-γmRNA were detected by RT-PCR;the expression of IL-12、IL-4 and IFN-γin culture supernatant of AdV-TLR4-transfected DCs were detected by ELISA assay;specific immunity marker proteins on the surface of AdV-TLR4-transfected DCs including Ia,CD40,CD80 and CD 86 were detected by flow cytometry.
4.Asthma mouse model was prepared with hypodermical injection of 0.1 %OVA Al(OH)3 solution and atomization of 1%OVA normal saline solution; tissue fixation with formalin,embedment,slice,HE stain and AB/PAS re-stain for mouse lung tissue morphologic observation.Eos in BALF was observed after Gimsa—Wright stain;the DCs were obtained through bone marrow cells separation,red blood cells treatement with lysate,induction of GM-CSF and IL-4,and RMPI 1640 culture,the expression level of both DCTLR4 mRNA and TLR4 protein of asthma mice were detected;IL-4、IL-5、IFN-γ,serum IgE level of mice spleen cells,human serum IL-4 and IgE,and IL-4 and IgE in BALF were detected via ELISA;CD4+ and CD25+ spleen cells percentage were detected with flow cytometry.
Result
1.Mouse TLR4 gene cDNA obtained from PCR has a full length of 2508bp and encodes 536 amino acids.The result of blast indicated this cDNA was 100%homologous with the one(sequence NO.NM021297)reported in Genbank.
2.PCR and enzyme digestion identification of recombinant plasmid showed:gene TLR4 was set correctly;pBHGF35 backbone plasmid was transfected into 293 cells and was packaged into virus.PCR assay proved the package of recombinant virus was finishend;the recombinant virus was transfected into mouse DCs and the TLR4 mRNA and TLR4 proteins were highly expressed.
3.1.L-12 and IFN-γ(inducing Th1 differentiation)were highly expressed 48 hours after DCs were transfected by Ad-TLR4,while,IL-4(inducing Th2 differentiation)showed a decreasing expression;PCR assay of transfected DC showed that the changes in IL-12 mRNA,IL-4 mRNA and IFN-γmRNA were consistent with the changes in corresponding proteins expression;LPS test indicated that LPS could effect the cytokines produced by transfected cells which were changed more greatly in LPS(+)group than that in LPS(-). LPS could also enhance some bionomics of Ad-TLR4-DC.2.Cytometry assay showed that CD86 was expressed more highly in Ad5F35-mTLR4 group than that in both control and Ad5F35-mCMV-EGFP group. Simultaneously,Ia,CD40 and CD80 of DC transfected by Ad5F35-mTLR4 were expressed much more highly in LPS(+)group than that in LPS(-)group; CD80 and CD86 in LPS(+)were more highly expressed than that in LPS(-) group.LPS may promote and strengthen the change of specific immunity marker proteins on the surface of Ad-TLR4-DCs.
4.When TLR4 DC suspension was given to the mice with allergic asthma,the result showed a decrease in beaker cell proliferation,mucosal fluid in airways,WBC,Eso ratio and IL-4 level.However the percentage of CD4+CD25+ cells increased,which indicating TLR4DC could resist bronchial asthma.The mechanism is possibly related to the cytokines induced by TLR4DCs and the former can promote T cells differentiation,for instance, IFN-γmay induce T11 differentiation;TLRC4DC may also increase immune-regulating T cells CD4+CD25+ that enhance the toleration of allergen and minimize the inflammation.
Conclusion
1.Full-length coding region cDNA of mouse TLR4 gene was successfully established.
2.Recombinant viral infection titer is 2.3×108 IU/ml and it can be utilized in animal experiment in vivo and in vitro.
3.LPS can lead to the change of specific immunity marker proteins on the surface of AdV-TLR4- DC including Ia,CD40,CD80 and CD 86,and it also result in the change of expression of IL-12,IL-4 and IFN-γsecreted by DC.These changes are presumed to be related to signal conduction of DCTLR4.
4.TLR4DC may inhibit the bronchial inflammation induced by OVA. Plus,LPS and TLR4 show a coordination which is possibly related to immune regulation of DC.
引文
[1]Ma Y,Hayglass KT,Becker A.B,et al.Novel cytokine peptide-based vaccines:an interleukin-4 vaccine suppresses airway allergic responses in mice[J].Allergy.2007;62(6):675-82
[2]Vandenbulcke L,Bachert C,Van Cauwenberge P,et al.The innate immune system and its role in allergic disorders[J].Int Arch Allergy Immunol.2006;139(2):159-65.
[3]Lee CW,Matulonis UA,Castells MC.Carboplatin hypersensitivity:a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions[J].Gynecol Oncol.2004;95(2):370-6.
[4]唐深.TLR家族及其功能研究进展[J].微生物学免疫学进展,2004;32(2):42-5
[5]余玉明.TOLL样受体与移植免疫[J].国外医学移植与血液净化分册,2005;3(6):34-7
[6]Amati L,Pepe M,Passeri ME,Mastronardi ML,et al.,Covelli V.Toll-like receptor signaling mechanisms involved in dendritic cell activation:potential therapeutic control of T cell polarization[J].Curr Pharm Des.2006;12(32):4247-54.
[7]Tang C,Inman MD,van Rooijen N,et al.The type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism[J].J lmmunol.2001;166(3):1471-81.
[8]Akdis M,Trautmann A,Klunker S,et al.T helper(Th)2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Thl cells[J].FASEB J,2003;17(9):1026-35.
[9]Pai SY,Truitt ML,Ho IC.GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells[J].Proc Natl Acad Sci U S A,2004;101(7):1993-8.
[10]Pernis AB,Rothman PB.JAK-STAT signaling in asthma[J].J Clin Invest,2002;109(10):1279-83.
[11]Hofer T,Nathansen H,Lohning M,et al.GATA-3 transcriptional imprinting in Th2lymphocytes:A mathematical model[J].Proc Natil Acad Sci USA,2002;99(14):9364-8.
[12]Skapenko A,Lipsky PE,Kraetsch HG,et al.Antigen-Independent Th2 Cell Differentiation by Stimulation of CD28:Regulation Via IL-4 Gene Expression and Mitogen-Activated Protein Kinase Activation[J].J Immunol,2001;166(7):4283-92.
[13]Bueving HJ,van der Wouden JC.What is the role of virus vaccination in patients with asthma[J]? Curr Allergy Asthma Rep.2007;7(1):72-6
[14]Barton GM.Viral recognition by Toll-like receptors[J].Semin Immunol.2007;19(1):33-40.
[15]Kabelitz D.Expression and function of Toll-like receptors in T lymphocytes[J].Curr Opin Immunol.2007;19(1):39-45
[16]Kallinich T,Beier KC,Wahn U,et al.T-cell co-stimulatory molecules:their role in allergic immune reactions[J].Eur Respir J.2007;29(6):1246-55.
[17]Fedele G,Celestino I,Spensieri F,et al.Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response[J].Microbes Infect.2007 12;[Epub ahead of print]
[18]Uchida T,Scumpia PO,Murasko DM,et al.Variable requirement of dendritic cells for recruitment of NK and T cells to different TLR agonists[J].J Immunol.2007 15;178(6):3886-92
[19]Bauer S,Hangel D,Yu P.Immunobiology of toll-like receptors in allergic disease[J].Immunobiology.2007;212(6):521-33.
[20]Medzhitov R,Preston HP,Janeway CA.A human homologue cf the Drosophila Toll protein signals activation of adaptive immunity[J].Nature,1997;388(6640):394-7.
[21]Bell JK,Botos I,Hall PR,et al.The molecular structure of the TLR3 extracellular domain[J].J Endotoxin Res.2006;12(6):375-8.
[22]Delneste Y,Beauvillain C,Jeannin P.Innate immunity:structure and function of TLRs[J].Med Sci.2007;23(1):67-73.
[23]Mayer AK,Muehmer M,Mages J,et al.Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells[J].J Immunol.2007;178(5):3134-42.
[24]Sukkar MB,Xie S,Khorasani NM,et al.Toll-like receptor 2,3,and 4 expression and function in human airway smooth muscle[J].J Allergy Clin Immunol.2006;118(3):641-8
[25]Komiya A,Nagase H,Okugawa S,et al.Expression and function of toll-like receptors in human basophils[J].Int Arch Allergy Immunol.2006;140 Suppl 1:23-7.
[26]Sugawara Y,Uehara A,Fujimoto Y,et al.Toll-like receptors,NOD1,and NOD2 in oral epithelial cells[J].J Dent Res.2006;85(6):524-9.
[27]Remer KA,Brcic M,Sauter KS,et al.Human monocytoid cells as a model to study Toll-like receptor-mediated activation[J].J Immunol Methods.2006 Jun 30;313(1-2):1-10.
[28]Kumar A,Yu FS.Toll-like receptors and corneal innate immunity[J].Curr Mol Med.2006;6(3):327-37.
[29]Spachidou MP,Bourazopoulou E,Maratheftis CI,et al.Expression of functional Toll-like receptors by salivary gland epithelial cells:increased mRNA expression in cells derived from patients with primary Sjogren's syndrome[J].Clin Exp lmmunol.2007;147(3):497-503.
[30]Carlo E,Rosenberg IM,Brandwein SL,et al.Lipopolysaccharide activate distinct signaling pathways in intestinal epithelial cell lines expressing Toll like receptors[J].J Immunol,2000;164(2):966-72.
[31]Frantz S,Kobzik L,Kim YD,et al.TLR4 expression in cardiac myocytes in normal and failing myocardium[J].J Clin Invest,1999;104(3):271-80
[32]Arbour NC,Lorenz E,Schutte BC,et al.TLR4 mutation are association witt endotoxin hyporesponsiveness in humans[J].Blat Genet,2000;25(2):187-91.
[33]Su GL,Klein RD,Aminlari A,et al.Kupffer cell activation by lipopolysaccharide in rats:role for !ipopolysaccharide binding protein an,toil-like receptor 4[J].Hepatology,2000;31(4):934-6.
[34]Chow JC,Young DW,Golenbock DT,et al.ToiF!ike recepor-4 mediate,lipopolysa～charideinduced signal tmnsduction[J].J Biol Chem,1999;27(16):10689-92.
[35]Lin Y,Lee H,Berg AH,et al.The lipopolysaecharide-activited toll like receptor4 induces synthesis of the dosely related receptor TLR-2 in adipocyte[J].J Biol Chem,2000;275(32):24255-63.
[36]Nomura F,Akashi S,Sakao Y,et al.Endotoxin tolenrance in mouce peritoneal macrophage correlates with down-regulation of surface toll-lik receptor 4 expression[J].J Immunoi,2000,164(7):3476-79.
[37]Kleeberger SR,Reddy S,Zhang LY,et al.Genetic susceptibility to ozone-induced lung hyperlneability:role of toil- like receptor 4[J].Am J Respir Cell Md Bid,2000;22(5):620-7.
[38]Medzhitov R.TLR-mediated innate immune recognition[J].Semin Immunol.2007;19(1):1-2.
[39]Kawai T,Akira S.TLR signaling[J].Semin Immunol.2007;19(1):24-32.
[40]Akashi-Takamura S,Miyake K.Toll-like receptors(TLRs)and immune disorders[J].J Infect Chemother.2006;12(5):233-40
[41]Kaisho T,Akira S.Toll-like receptor function and signaling[J].J Allergy Clin Immunol.2006;117(5):979-87
[42]Wang J,Shao Y,Bennett TA,et al.The functional effects of physical interactions among Toll-like receptors 7,8,and 9[J].J Biol Chem.2006;281(49):37427-34.
[43]Johnson GB,Brunn GJ,Tang AH,et al.Evolutionary dues to the functions of the Toil-like family as surveillance receptors[J].Trends.Immunol,2003;24(1):19-24.
[44]Wagner H.Endogenous TLR ligands and autoimmunity[J].Adv Immunol.2006;91:159-73.
[45]Taylor RC,Richmond P,Upham JW.Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen[J].J Allergy Clin Immunol.2006;117(5):1148-54.
[46]Johansen P,Senti G,Martinez Gomez JM,et al.Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy[J].Clin Exp Allergy.2005;35(12):1591-8.
[47]Huang B,Zhao J,Shen S,et al.Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling[J].Cancer Res.2007;67(9):4346-52.
[48]Homg T,Barton GM,Flavell RA,et al.The adaptor molecule TIRAP provides signaling specificity for Toil-like receptors[J].Nature,2002,;420:329-3.
[49]Homg T,Barlon GM,Medzhitov R.TIRAP:an adaptor molecule in the Toll signaling pathway [J].Nat hnmunol,2001,;2(9):835;41.
[50]Carmody RJ,Chen YH.Nuclear factor-kappaB:activation and reguation during toll-like receptor signaling[J].Cell Mol Immunol.2007;4(1):31-41.
[51]Purcell MK,Smith KD,Hood L,et al.Conservation of Toll-Like Receptor Signaling Pathways in Teleost Fish[J].Comp Biochem Physiol Part D Genomics Proteomics.2006;1(1):77-88.
[52]Lemmers B,Salmena L,Bidere N,et al.Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling[J].J Biol Chem.2007 Mar 9;282(10):7416-23.Epub 2007 Jan 9.
[53]Fitzgerald KA,Chen ZJ.Sorting out Toll signals[J].Cell.2006 2;125(5):834-6.
[54]Oda K,Kitano H.A comprehensive map of the toll-like receptor signaling network[J].Mol Syst Biol.2006;2:2006.0015.
[55]Akira S.TLR signaling[J].Curr Top Microbiol Immunol.2006;311:1-16
[56]Pandey S,Agrawal DK.Immunobiology of Toll-like receptors:emerging trends[J].Immunol Cell Biol.2006;84(4):333-41.
[57]Bachar O,Adner M,Uddman R,et al.Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin,an effect mediated by JNK and NF-kappa B signaling pathways[J].Eur J Immunol.2004;34(4):1196-207.
[58]Wang J,Wang X,Hussain S,et al.Distinct Roles of Different NF-{kappa}B Subunits in Regulating Inflammatory and T Cell Stimulatory Gene Expression in Dendritic Cells[J].J Immunol.2007;178(11):6777-88.
[59]Carmody RJ,Chert YH.Nuclear factor-kappaB:activation and regulation during toll-like receptor signaling[J].Cell Mol Immunol.2007;4(1):31-41
[60]Doyle SL,O'Neill LA.Toll-like receptors:from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity[J].Biochem Pharmacol.2006;72(9):1102-13.
[61]Qian C,An HZ.The effects and their mechanism study of TLRs in adaptability immunity[J].Foreign Meical Sciences Section of Immunology,2005:28(1):16-9
[62]Imanishi T,Hara H,Suzuki S,et al.Cutting Edge:TLR2 Directly Triggers Thl Effector Functions[J].J Immunol.2007;178(11):6715-9
[63]Imanishi T,Hara H,Suzuki S,et a/.Cutting Edge:TLR2 directly triggers Th1 effector functions.J Immunol.2007;178(11):6715-9.
[64]Bekeredjian-Ding I,Roth SI,Gilles S,et al.T cell-independent,TLR-induced IL-12p70production in primary human monocytes[J].J Immunol.2006 Jun 15;176(12):7438-46.
[65]Sutmuller RP,Morgan ME,Netea MG,et al.Toll-like receptors on regulatory T cells:expanding immune regulation[J].Trends Immunol.2006;27(8):387-93
[66]Homer AA.Update on toll-like receptor ligands and allergy:implications for immunotherapy[J].Curr Allergy Asthma Rep.2006;6(5):395-401.
[67]Camateros P,Tamaoka M,Hassan M,et al.Chronic Asthma Induced Airway Remodeling is Prevented by the Toll-like Receptor 7/8 Ligand $28463[J].Am J Respir Crit Care Med.2007;[Epub ahead of print]
[68]Shan X,Hu A,Veler H,et al.Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling[J].Am J Physiol Lung Cell Mol Physiol.2006;291(3):L322-3.
[69]Fedele G,Celestino I,Spensieri F,et al.Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response[J].Microbes Infect.2007;9(7):855-63.
[70]Su MS.TLRs and.immunological regulation of asthma[J].Foreign Meical Sciences Section of Pediatrics,2005;32(2):92-5
[71]Nigo YI,Yamashita M,Hirahara K,et al.Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function[J].Proc Natl Acad Sci U S A.2006;103(7):2286-91
[72]Nigo YI,Yamashita M,Hirahara K,et al.Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function[J].Proc Nail Acad Sci U S A.2006;103(7):2286-91.
[73]Pawankar R.Mast cells in allergic airway disease and chronic rhinosinusitis[J].Chem Immunol Allergy.2005;87:111-29.
[74]梁峰 胡大一 王伯瑶.Toll样受体-4在人肺腺上皮细胞、单核细胞和脐静脉血管内皮细胞的表达[J].山西医科大学学报,2004;35(2);101-3
[75]万幸,王培训,周联.脂多糖刺激前后小鼠肺肝脾组织中Toll样等受体基因表达情况[J].中国危重病急救医学.2004;16(2):73-6
[76]Samarasinghe R,Tailor P,Tamura T,et al.Induction of an anti-inflammatory cytokine,IL-10,in dendritic cells after toll-like receptor signaling[J].J Interferon Cytokine Res.2006;26(12):893-900.
[77]Bhattacharjee RN,Akira S.Modifying toll-like receptor 9 signaling for therapeutic use[J].Mini Rev Med Chem.2006;6(3):287-91.
[78]Ritter M,Mennedch D,Weith A,et al.Characterization of Toll-like receptors in primary lung epithelial cells:strong impact of the TLR3 ligand poly(I:C)on the regulation of Toll-like receptors,adaptor proteins and inflammatory response[J].J Irfflamm(Lond).2005;2(1):16-20
[79]Greene CM,McElvaney NG.Toll-like receptor expression and function in airway epithelial cells[J].Arch Immunol Ther Exp(Warsz).2005;53(5):418-27
[80]Mayer AK,Muehmer M,Mages J,et al.Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells[J].J Immunol.2007;178(5):3134-42.
[81]Bemdt A,Derksen FJ,Venta PJ,et al.Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction[J].Am J Physiol Lung Cell Mol Physiol.2007;292(4):L936-43.
[82]Schmeck B,Huber S,Moog K,et al.Pneumococci induced TLR- and Racl-dependent NF-kappaB-recruitment to the IL-8 promoter in lung epithelial cells[J].Am J Physiol Lung Cell Mol Physiol.2006;290(4):L730-L737
[83]Hauber I-IP,Tulic MK,Tsicopoulos A,et al.Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis[J]..Can Respir J.2005 Jan-Feb;12(1):13-8.
[84]Hertz CJ,Wu Q,Porter EM,et al.Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2[J].J Immunol.2003Dec 15;171(12):6820-6.
[85]Becker MN,Diamond G,Verghese MW,et al.CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium[J].J Biol Chem.2000 Sep 22;275(38):29731-6.
[86]Pandey S,Agrawal DK.Immunobiology of Toll-like receptors:emerging trends[J].Immunol Ceil Biol.2006;84(4):333-41.
[87]Radhakrishnan S,Wiehagen KR,Pulko V,et al.Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells:dependence on TCR:peptide-MHC interaction,ICAM-1,IL-12,and IFN-gamma[J].J Immunol.2007 15;178(6):3583-92.
[88]Marsland BJ,Nembrini C,Griin K,et al.TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myoearditis[J].J Immunol.2007 Mar 15;178(6):3466-73.
[89]Kabelitz D,Wesch D,Oberg HH.Regulation of regulatory T cells:role of dendritic cells and toll-like receptors[J].Crit Rev Imrnunol.2006;26(4):291-306.
[90]Arnati L,Pepe M,Passeri ME,et al.Toll-like receptor signaling rneehanisms involved in dendritic cell activation:potential therapeutic control of T cell polarization[J].Curr Pharm Des.2006;12(32):4247-54.Review.
[91]Medzhitov R,Preston HP,Janeway CA.A human homologne ef the Drosophila Toil protein signals activation of adaptive immunity[J].Nature,1997;388(6640):394-7.
[92]Sehra S,Pynaert G,Toumoy K,et al.Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma[J].J Imrnunol,2003;171(4):2080-9.
[93]Viney JL.Dentritie cell subsets:the ultimate T cell differentiation decision makers[J]? Gut,1999;45(5):640-1.
[94]Terhorst D,Kalali BN,Weidinger S,et al.Monoeyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands[J].Clin Exp Allergy.2007;37(3):381-90.
[95]Demedts IK,Braeke KR,Maes T,et al.Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms[J].Am J Respir Cell Mol Biol.2006;35(3):387-93.
[96]Watts C,Zaru R,Prescott AR,et al.Proximal effects of Toll-like receptor activation in dendritic cells[J].Curr Opin Immunol.2007;19(1):73-8.
[97]Xu L.Toll like protein[J].Chemistry Of Life,2003;23(1):36-8
[98]Hubert FX,Voisine C,Louver C,et al.Josien R.Differential pattemrecognition receptor expression but stereotyped responsiveness in rat spleen dendritic cell subsets[J].J Immunol.2006;177(2):1007-16.
[99]Zhou AM,Feng J.Study on Toll like receptor differentiation of DC and signal transduction[J].Chin J Derm Venereol,2004;18(4):246-7
[100]Yang IA,Fong KM,Holgate ST,Holloway JW.The role of Toll-like receptors and related receptors of the innate immune system in asthma[J].Curr Opin Allergy Clin Immunol.2006;6(1):23-8
[101]Duez C,Gosset P,Tonnel AB.Dendritic cells and toll-like receptors in allergy and asthma[J].Eur J Dermatol.2006;16(1):12-6
[102]Redecke V,Hacker H,Datta SK,et al.Cutting edge:activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma[J].J Immunol.2004;172(5):2739-43
[103]Eisenbarth SC,Piggott DA,Huleatt JW,et al.Lipopolysaccharide-enhanced,toil-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen[j].J Exp Med.2002;196(12):1645-51.
[104]Ishii KJ,Uematsu S,Akira S.Toll' gates for future immunotherapy[J].Curt Pharm Des.2006;12(32):4135-42.
[105]Hoebe K,Jiang Z,Georgel P,et al.TLR signaling pathways:opportunities for activation and blockade in pursuit of therapy[J].Curt Pharm Des.2006;12(32):4123-34.
[106]Rezaei N.Therapeutic targeting of pattern-recognition receptors[J].Int Immunopharmacol.2006;6(6):863-9.
[107]Hayashi T,Raz E.TLR9-based immunotherapy for allergic disease[J].Am J Med.2006;119(10):897.e1-6.
[108]Bhattacharjee RN,Akira S.Modifying toll-like receptor 9 signaling for therapeutic use.Mini Rev Med Chem.2006 Mar;6(3):287-91.Modifying toll-like receptor 9 signaling for therapeutic use[J].Mini Rev Med Chem.2006;6(3):287-91.
[109]Cairns B,Maile R,Barnes CM,Frelinger JA,et al.Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after bum injury[J].J Trauma.2006;61(2):293-8
[110]Homer AA.Update on toll-like receptor ligands and allergy:implications for immunotherapy[J].Curr Allergy Asthma Rep.2006;6(5):395-401.
[111]Galdeano CM,Perdigon G.The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity[J].Clin Vaccine Immunol.2006;13(2):219-26.
[112]Dugas B,Mercenier A,Lenoir-Wijnkoop I.Immunity and Probioties[J].Immunol Today,1999,20(9):387-390.
[113]Yoshimura A,Lien E,Ingalls RR.Cutting edge:recognition of Gram-positive bacterial cell wall components by the innate immune systemoccurs via Toll-like receptor 2[J].J Immunol,1999,163(1):1-5.
[114]Rachmilewitz D,Katakura K,Karmeli F,et al.Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis[J].Gastroenterology.2004;126(2):520-8.
[115]Lee J,Rachmilewitz D,Raz E.Homeostatic effects of TLR9 signaling in experimental colitis[J].Ann N Y Acad Sci.2006;1072:351-5.
[116]Rachmilewitz D,Katakura K,Karmeli F,et al.Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis[J].Gastroenterology.2004;126(2):520-8.
[117]Hu X,Paik PK,Chert J,et al.IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins[J].Immunity.2006;24(5):563-74.
[118]Martin M,Rehani K,Jope RS,et al.Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3[J].Nat Immunol.2005;6(8):777-84.
[1]Karoly E,Fekete A,Banki NF,et al.Heat shock protein 72(HSPAIB)Gene Polymorphism and toll-like receptor(TLR)4 mutation are associated with increased risk of urinary tract infection in children[J].Pediatr Res.2007;61(3):371-4.
[2]Cheng I,Plummer S J,Casey G,et al.Toll-like receptor 4 genetic variation and advanced prostate cancer risk[J].Cancer Epidemiol Biomarkers Prey.2007;16(2):352-5.
[3]Jung YO,Cho ML,Kang CM,et al.Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts.Immunol[J].Lett.2007;109(1):21-7.
[4]Arbour NC,Lorenz E,Schutte BC,et al.TLR4 mutation are association with endotoxin hyporesponsiveness in humans[J].Nat Genet,2000;25(2):187-191.
[5]Kleeberger SR,Reddy S,Zhang LY,et al.Genetic susceptibility to ozone-induced lung hypermeability:role of toll-like receptor 4[J].AmJ Respir Cell Mol Biol,2000,22(5):620-627.
[6]Chow JC,Young DW,Golenbock DT,et al.Toll-like recepor 4 mediates lipopolysaccharide induced signal transduction[J].J Biol Chem,1999;274(16):10689-10692.
[7]Nomura F,Akashi S,Sakao Y,et al.Endotoxin tolenrance in mouce peritoneal macrophage correlates with down-regulation of surface toll-like receptor 4 expression[J].J Immunol,2000,164(7):3476-3479.
[8]Su GL,Klein RD,Aminlari A,et al.Kupffer cell activation by lipopolysaecharide in rats:role for lipopolysaecharide binding protein and toll-like receptor 4[J].Hepatology,2000,31(4):934-936.
[9]Lin Y,Lee H,Berg AH,et al.The lipopolysaccharide2activited toll-like receptor-4 induces synthesis of the closely related receptor TLR22 in adipocyte[J].J Biol Chem,2000,275(32):24255-24263.
[10]Cario E,Rosenberg IM,Brandwein SL,et al.Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors[J]J Immunol,2000,164(2):966-972.
[11]Frantz S,Kobzik L,Kirn YD,et al.TLR4 expression in cardiac myocytes in normal and failing myocardium[J].J Clin Invest,1999,104(3):271-280.
[12]Rodriguez D,Keller AC,Faquim-Mauro EL,et al.Bacterial lipopolysaecharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2activity[J].J Immunol,2003,17(2):1001-1008.
[13]Kurt-Jones EA,Popova L,Kwinn L,et al.Pattern recognition receptors TLR4 and CD14mediate response to respiratory syncytial vires[J].Nat Immunol,2000;1(5):398-401.
[14]EisenbarthSC,PiggottDA,HuleattJW,et al.Lipopolysaecharide-enhanced,toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen[J].J ExpMed,2002,16,196(12):1645-1651.
[15]Erddge C,Moncayo-Nieto OL,Morgan R,et al.Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[16]Duez C,Gosset P,Tonnel AB.Dendritic cells and toll-like receptors in allergy and asthma[J].Eur J Dermatol.2006;16(1):12-6.
[17]Poltorak A,He X,Smimova I,et al.Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in Tlr4 gene[J].Science.1998;282(5396):2085-8.
[18]Okayama N,Fujimura K,Suehiro Y,et al.Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness[J].J Clin Lab Anal.2002;16(1):56-8.
[19]En-idge C,Moncayo-Nieto OL,Morgan R,et al.Acinetobacter baumannii activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[20]Puthothu B,Forster J,Heinzmann A,et al.TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease[J].Dis Markers.2006;22(5-6):303-8
[21]Barber RC,Aragaki CC,Rivera-Chavez FA,et al.TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following bum injury[J].J Med Genet.2004;41(11):808-13.
[1]Osten P,Grinevich V,Cetin A.Viral vectors:a wide range of choices and high levels of service.Handb Exp Pharmacol[J].2007;178:177-202
[2]Yotnda P,Savoldo B,Charlet-Berguerand N,et al.Targeted delivery of adenoviral vectors by cytotoxic T cells[J].Blood.2004;104(8):2272-80.
[3]Kang BN,Deshpande DA,Tirumurugaan KG,et al.Adenoviral mediated anti-sense CD38attenuates TNF-alpha-induced changes in calcium homeostasis of human airway smooth muscle cells[J].Call J Physiol Pharmacol.2005;83(8-9):799-804.
[4]Mancheno-Corvo P,Martin-Duque P.Viral gene therapy[J].Clin Transl Oncol.2006;8(12):858-67.
[5]Erridge C,Moncayo-Nieto OL,Morgan R,et al.Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[6]Duez C,Gosset P,Tonnel AB.Dendritic cells and toll-like receptors in allergy and asthma[J].Eur J Dermatol.2006;16(1):12-6.
[7]Okayama N,Fujimura K,Suehiro Y,et al.Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness[J].J Clin Lab Anal.2002;16(1):56-8.
[8]Erridge C,Moncayo-Nieto OL,Morgan R,et al.Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[9]Puthothu B,Forster J,Heinzmann A,et al.TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease[J].Dis Markers.2006;22(5-6):303-8
[10][10]Barber RC,Aragaki CC,Rivera-Chavez FA,et al.TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury[J].J Med Genet.2004;41(11):808-13.
[11]裴丽红,刘祝公,陈慰峰。小鼠胸腺树突状细胞系的克隆化及基本鉴定[J]。中国免疫学杂志。1999;15(6):257-9
[12]Graham FL,Prevec L.Methods for construction of adenovirus vectors[J].Mol Biotechnol.1995;3(3):207-20.
[13]Li X,Fan R,Zou X,Gao L,et al.Inhibitory effect of recombinant adenovirus carrying immunocaspase-3 on hepatocellular carcinoma[J].Biochem Biophys Res Commun.2007;358(2):489-94.
[14]Pyles RB,Warnick RE,Chalk CL,et al.A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors[J].Hum Gene Ther.1997 Mar 20;8(5):533-44.
[15]Kramm CM,Chase M,Herrlinger U,et al.Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy[J].Hum Gene Ther.1997;8(17):2057-68.
[16]Collaco RF,Cao X,Trempe JP.A helper virus-free packaging system for recombinant adeno-associated virus vectors[J].Gene.1999;238(2):397-405.
[17]Grimm D,Kern A,Rittner K,Kleinschmidt JA.Novel tools for production and purification of recombinant adenoassociated virus vectors[J].Hum Gene Ther.1998;9(18):2745-60.
[18]Kreppel F,Gackowski J,Schmidt E,et al.Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors[J].Mol Ther.2005;12(1):107-17.
[19]Sakurai F,Mizuguchi H,Yamaguchi T,et al.Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector[J].Mol Ther.2003;8(5):813-21
[20]Kostense S,Koudstaal W,Sprangers M,et al.Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector[J].AIDS.2004 21;18(8):1213-6.
[21]Karoly E,Fekete A,Banki NF,et al.Heat shock protein 72(HSPA1B)Gene Polymorphism and toll-like receptor(TLR)4 mutation are associated with increased risk of urinary tract infection in children[J].Pediatr Res.2007;61(3):371-4.
[22]Cheng I,Plummer SJ,Casey G,et al.Toll-like receptor 4 genetic variation and advanced prostate cancer risk[J].Cancer Epidemiol Biomarkers Prev.2007;16(2):352-5.
[23]Jung YO,Cho ML,Kang CM,et al.Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts[J].Immunol Lett.2007;109(1):21-7.
[24]Okayama N,Fujimura K,Suehiro Y,et al.Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness[J].J Clin Lab Anal.2002;16(1):56-8.
[25]Erridge C,Moncayo-Nieto OL,Morgan R,,et al.Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[26]Puthothu B,Forster J,Heinzmann A,et al.TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease[J].Dis Markers.2006;22(5-6):303-8
[27]Barber RC,Aragaki CC,Rivera-Chavez FA,et al.TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following bum injury[J].J Med Genet.2004;41(11):808-13.
[1]Ueno H,Klechevsky E,Morita R,et al.Dendritic cell subsets in health and disease[J].Immunol Rev.2007;219(1):118-42.
[2]曹雪涛.树突状细胞与肿瘤的免疫治疗和基因治疗[J].中国肿瘤生物治疗杂志,1998;5(2):82-84.
[3]Banchereau J,Steinman R M.Dendritic cells and the control of immunity[J].Nature,1998;392(6673):245-252.
[4]Steinman R M,Pope M.Exploiting dendritic cells to improve vaccine ef-ficacy[J].J Clin Invest J,2002;109(12):1519-1526.
[5]Caux C,Massacri C,Vanbervliet B,et al.CD34+ Hematopoietic Progen-itors FromHuman Cord Blood Differentiate AlongTwo Independent Den-dfitic Cell Pathways in Response to Granulocyte-Macrophage Colony-Stimulating Factor Plus Tumor Necrosis Factor:Ⅱ.Functional Analysis[J].J Blood,1997;90(4):1458-1470.
[6]Rouard H,Leon A,Klonjkowski B,et al.Adenoviral transduction of hu-man'clinical grade'immuature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity[J].J Immunol Method B,2000;241(1-2):69-81.
[7]曹雪涛,叶天星.树突状细胞研究在免疫学中的意义及其发展趋势[J].国外医学·免疫学分册,1998:21(6):281-285.
[8]Anita Reddy,Mark Sapp,Mary Feldman,et al.A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Ter-minal Maturation of Human Dendritic cells[J].JBlood,1997;90(9):3641-3646.
[9]吴松泉.细胞免疫中共刺激分子研究进展[J].国外医学·免疫学分册,2000;23(1):16-18.
[10]Mosca PJ,Lyerly HK,Clay TM,et al.Dendritic cell vaccines[J].Front Biosci.2007;12:4050-60.Review.
[11]Awasthi S.Dendritic cell- based vaccine against Coccidioides infection[J].Ann N Y Acad Sci.2007;[Epub ahead of print]
[12]hang S,Wang Q,Miao B.Review:dendritic cell-based vaccine in the treatment of patients with advanced melanoma[J].Cancer Biother Radiopharm,2007;22(4):501-7.
[13]Moiseyenko V,Imyanitov E,Danilova A,et al.Cell technologies in immunotherapy of cancer [J].Adv Exp Med Biol.2007;601:387-93.
[14]Ranieri E,Gigante M,Storkus WJ,et al.Translational mini-review series on vaccines:Dendritic cell-based vaccines in renal cancer[J].Clin Exp Immunol.2007;147(3):395-400.Review.
[15]Pal C,Ganguly D,Paul K,Pal S.Dendritic cells and antigen trapping technology--a revolution in vaccine/immunotherapy strategy[J].Indian J Exp Biol.2007;45(6):491-504.Review.
[16]Kugler A,Stuhler G,Walden P.Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hy-bdds[J].Nat Med,2000;6(3):332-336.
[17]Murphy GP,Tjon BA,Simmons SJ,et al.Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides:a phase Ⅱ prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease[J].Prostate,1999;38(1):73-78.
[18]Ashley DM,Faiola B,Nair S,et al.Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immu-nity against central nervous system tumors[J].J ExpMed,1997;186(7):1177-1182.
[19][19]Ojima T,Iwahashi M,Nakamura M,et al.Benefits of gene tra nsduction of granulocyte macrophage colony-stimulating facto r in cancer vaccine using genetically modified dendritic cells[J].Int J Oncol.2007;31(4):931-9.
[20]Ovali E,Dikmen T,Sonmez M,et al.Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine:a safety study[J].J Exp Clin Cancer Res.2007;26(2):209-14.
[21]Ishida T,Chada S,Stipanov M,et al.Dendritic cells transduced with wild-type p53gene elicit potent anti-tumour immune respo nses[J].Clin Exp Immunol,1999;117(2):244-251.
[22]Melero I,Duarte M,Ruiz J,et al.Intratumoral injection of bone-mar-row derived dendritic cells engineered to produce intedeukin-12in-duces complete regression of established murine transplantable colon adenocarcinomas[J].Gene Ther,1999;6(10):1779-1784.
[23]Perez-Diez A,Marincola FM.Immunotherapy against anti-genie tu-mors:a game with a lot of players.Cell Mol Life Sci,2002;59(2):230-240.
[24]van Duin D,Shaw AC.Toll-like receptors in older adults.J Am Geriatr Soc.2007;55(9):1438-44.
[25]Chinen J,Shearer WT.Advances in basic and clinical immunologyin 2006.J Allergy Clin Immunol.2007;120(2):263-70.
[1]Bharadwaj AS,Bewtra AK,Agrawal DK.Dendritic cells in allergic airway inflammation[J].Can J Physiol Pharmacol.2007;85(7):686-699.
[2]Aiba S.Dendritic cells-importance in allergy[J].Allergol Int.2007;56(3):201-8.
[3]Shinohara ML,Cantor H.The bridge between dendritic cells and asthma[J].Nat Med.2007;13(5):536-8.
[4]Kuipers H,Heirman C,Hijdra D,et al.Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2sensitization[J].J Leukoc Biol.2004;76(5):1028-38.
[5]Holt PG,Upham JW.The role of dendritic cells in asthma[J].Curr Opin Allergy Clin Immunol.2004;4(1):39-44.
[6]Weber-Chrysochoou C,Crisafulli D,Almqvist C,et al.for the Childhood Asthma Prevention Study Investigators.IL-5 T-cell responses to house dust mite are associated with the development of allergen-specific IgE responses and asthma in the first 5 years of life[J].J Allergy Clin Immunol.2007;120(2):286-92.
[7]Khor YH,Feltis BN,Reid DW,et al.Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction[J].Clin Exp Allergy.2007;37(8):1189-98.
[8]Homg T,Barton GM,Flavell RA,et al.The adaptor molecule TIRAP provides signaling specificity for Toil-like receptors[J].Nature,2002,;420:329-3.
[9]Homg T,Barlon GM,Medzhitov R.TIRAP:an adaptor molecule in the Toll signaling pathway [J].Nat hnmunol,2001;2(9):835;41.
[10]Carmody RJ,Chen YH.Nuclear factor-kappaB:activation and regulation during toll-like receptor signaling[J].Cell Mol Immunol.2007;4(1):31-41.
[11]Purcell MK,Smith KD,Hood L,et al.Conservation of Toll-Like Receptor Signaling Pathways in Teleost Fish[J].Comp Biochem Physiol Part D Genomics Proteomics.2006;1(1):77-88.
[12]Lemmers B,Salmena L,Bidere N,et al.Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling[J].J Biol Chem.2007;282(10):7416-23.
[13]Fitzgerald KA,Chen ZJ.Sorting out Toll signals[J].Cell.2006 2;125(5):834-6.
[14]Oda K,Kitano H.A comprehensive map of the toll-like receptor signaling network[J].Mol Syst Biol.2006;2:2006-15.
[15]Akira S.TLR signaling[J].CurrTop Microbiol Immunol.2006;311:1-16
[16]Pandey S,Agrawal DK.Immunobiology of Toll-like receptors:emerging trends[J].Immunol Cell Biol.2006;84(4):333-41.
[17]Bachar O,Adner M,Uddman R,et al.Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin,an effect mediated by JNK and NF-kappa B signaling pathways[J].Eur J Immunol.2004;34(4):1196-207.
[18]Wang J,Wang X,Hussain S,et al.Distinct Roles of Different NF-{kappa}B Subunits in Regulating Inflammatory and T Cell Stimulatory Gene Expression in Dendritic Cells[J].J Immunol.2007;178(11):6777-88.
[19]Carmody RJ,Chen YH.Nuclear factor-kappaB:activation and regulation during toll-like receptor signaling[J].Cell Mol Immunol.2007;4(1):31-41
[20]Doyle SL,ONeill LA.Toll-like receptors:from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity[J].Biochem Pharmacol.2006;72(9):1102-13.
[21]DABBAGH K,DAHL ME,LEWlS DB.Toll-like Receptor 4is Required for Optimal Development of Th2 Immune Response:role of Dent ritic Cells[J].J Immunol,2002;168(9):4524-4530.
[22]KUIPERS H,HIJDRA D,DE VRIES VC,et al.Lipopolysac- charide Induced Suppression of Airway Th2 Reponses doesnot Require IL-12 Production by Dent ritic Cells[J].J Immunol,2003;171(7):364523654.
[23]EISENBARTH SC,PIGGOT DA,HUL EATT JW,et al.Lipopolysaccharide Toll-like Receptor 4-Dependent T Helper Cell Type 2 Responses to Inhaled Antigen[J].J Exp Med,2002;196(12):164521651.
[24]CARAMAL HO I,LOPES-CARVAL HO T,OSTLER D,et al.Reguratory T Cells Selectively Express Toll-like Receptors and are Activated by Lipopolysacchadde[J].J Exp Med.2003;197(4):4032411.
[25]RESCIGNO M,URBANO M,RIMOLDI M,et al.Toll-like Receptor 4 is not Required for the Full Maturation of Dent ritic Cells or for t he Degradation of Gram-negative Bacteria[J].Surg Today.2007;37(10):867-73
[26]Ueno A,Murasaki K,Hagiwara N,el al.Increases in circulating T lymphoeytes expressing HLA-DR and CD40 ligand in patients with dilated cardiomyophthy[J].Heart Vessels.2007;22(5):316-21.
[27]Richards KA,Chaves FA,Krafcik FR,el al.Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DRl-restricted CD4 T-cell response to influenza virus hemagglutinin[J].J Virol.2007;81(14):7608-19.
[28]Wozniacka A,Lesiak A,Narbutt J,el al.Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus[J].Lupus.2007;16(2):89-94.
[29]Stewart R,Wei W,Challa A,el al.CD154 Tone Sets the Signaling Pathways and Transcdptome Generated in Model CD40-Pluricompetent L3055 Burkitt's Lymphoma Cells[J].J Immunol.2007;179(5):2705-12.
[30]Tousoulis D,Antoniades C,Nikolopoulou A,el al.Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes[J].Eur J Clin Invest.2007;37(8):623-8.
[31]Toutirais O,Gervais A,Cabillic F,el al.Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro[J].Clin Exp Immunol.2007;149(2):372-7.
[32]Thomas GR,Wen J.Endogenous expression of CD80 co-stimulatory molecule facilitates in vivo tumor regression of oral squamous carcinoma[J].Anticancer Res.2006;26(6B):4093-101.
[33]Sharma S,Chopin K,Kulkami SK,el al.Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway[J].Clin Exp Immunol.2007;147(1):155-63.
[34]Crosby JR,Guha M,Tung D,el al.Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice[J].J Pharmacol Exp Ther.2007;321(3):938-46.
[35]Lee JB,Lee KA,Chang J.Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation[J].Int Immunol.2007;19(9):1039-48..
[36]Hirota T,Suzuki Y,Hasegawa K,el al.Functional haplotypes of IL-12B are associated with childhood atopic asthma[J].J Allergy Clin Immunol.2005;116(4):789-95.
[37]Wu C,Yang G,Bermudez-Humaran LG;el al.Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin(OVA)-induced asthma model mice[J].Int Immunopharmacol.2006;6(4):610-5.
[38]Fu CL,Ye YL,Lee YL,el al.Effects of overexpression of IL-10,IL-12,TGF-beta and IL-4 on allergen induced change in bronchial responsiveness[J].Respir Res.2006;7:72.
[39]Hellings PW,Kasran A,Bullens D,el al.IL-10- and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling[J].J Immunol.2006;177(8):5138-44.
[40]Meyts I,Hellings PW,Hens G,el al.IL-12 contributes to allergen-induced airway inflammation in experimental asthma[J].J Immunol.2006;177(9):6460-70.
[41]Cooper AM,Khader SA.IL-12p40:an inherently agonistic cytokine[J].Trends Immunol.2007;28(1):33-8.
[42]Ando M,Shima M.Serum intedeukins 12 and 18 and immunoglobulin E concentrations and allergic symptoms in Japanese schoolchildren[J].J Investig Allergol Clin Immunol.2007;17(1):14-9.
[43]Sel S,Wegmann M,Sel S,el al.Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10[J].J Immunol.2007;178(12):7805-13.
[44]Isidoro-Garcia M,Davila I,Laffond E,el al.Intedeukin-4(IL4)and Intedeukin-4 receptor (IL4RA)polymorphisms in asthma:a case control study[J].Clin Mol Allergy.2005;3:15.
[45]Kabesch M,Schedel M,Carr D,el al.IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma[J].J Allergy Clin Immunol.2006;117(2):269-74.
[46]Fu CL,Ye YL,Lee YL,el al.Effects of overexpression of IL-10,IL-12,TGF-beta and IL-4 on allergen induced change in bronchial responsiveness[J].Respir Res.2006;7:72.
[47]Kim HA,Heo YJ,Lee SH,el al.No potential role of genetic polymorphisms for IL-4,IL-13 and IL-4 receptor in respiratory allergy:a study in adults working at social welfare facilities in Korea[J].J UOEH.2006 1;28(4):369-79.
[48]Mak JC,Ko FW,Chu CM,el al.Polymorphisms in the IL-4,IL-4 receptor alpha chain,TNF-alpha,and lymphotoxin-alpha genes and risk of asthma in Hong Kong Chinese adults[J].Int Arch Allergy Immunol.2007;144(2):114-22.
[49]Tavakkol Afshari J,Farid Hosseini R,Hosseini Farahabadi S,el al.Association of the Expression of IL-4 and IL-13 Genes,IL-4 and IgE Serum Levels with Allergic Asthma[J].Iran J Allergy Asthma Immunol.2007;6(2):67-72.
[50]Nieuwenhuizen N,Herbert DR,Lopata AL,el al.CD4+ T Cell-Specific Deletion of IL-4Receptor {alpha} Prevents Ovalbumin-Induced Anaphylaxis by an IFN-{gamma}-Dependent Mechanism[J].J Immunol.2007;179(5):2758-65.
[51]Karras JG,Crosby JR,Guha M,el al.Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice[J].Am J Respir Cell Mol Biol.2007;36(3):276-85
[52]Fang SP,Tanaka T,Tago F,el aI.Immunomodulatory effects of gyokuheifusan on INF-gamma/IL-4(l'hl/Th2)balance in ovalbumin(OVA)-induced asthma model mice[J].Biol Pharm Bull.2005;28(5):829-33.
[53]Koch M,Witzenrath M,Reuter C,el al.Role of local pulmonary IFN-gamma expression in murine allergic airway inflammation[J].Am J Respir Cell Mol Biol.2006;35(2):211-9
[54]Kumar RK,Webb DC,Herbert C,el al.Interferon-gamma as a possible target in chronic asthma[J].Inflamm Allergy Drug Targets.2006;5(4):253-6.
[55]Ito I,Laporte JD,Fiset PO,el al.Downregulation of a disintegrin and metalloproteinase 33 by IFN-gamma in human airway smooth muscle cells[J]Am J Respir Cell Mol Biol.2006;35(2):211-9.
[56]Wang G,Liu CT,Wang ZL,Yan CL,el al.Effects of Astragalus membranaceus in promoting T-helper cell type 1 polarization and interferon-gamma production by up-regulating T-bet expression in patients with asthma[J].Chin J Integr Med.2006;12(4):262-7.
[57]Gonzalez-Hernandez Y,Pedraza-Sanchez S,Bland6n-Vijil V,el al.Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma[j].Scand J lmmunol.2007;65(4):368-75.
[58]Wark PA,Bucchied F,Johnston SL,el al.IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations[J].J Allergy Clin Immunol.2007;120(3):586-93.
[59]Meng QR,Gideon KM,Harbo S J,et al.Gene expression profiling in lung tissues from mice exposed to cigarette smoke,lipopolysaccharide,or smoke plus lipopolysaccharide by inhalation[J].Inhal Toxicol.2006;18(8):555-68.
[60]Crume KP,Miller JH,La Flamme AC.Peloruside A,an antimitotic agent,specifically decreases tumor necrosis factor-alpha production by lipopolysaccharide-stimulated murine macrophages[J].Exp Biol Med.2007;232(5):607-13.
[61]del Olmo E,Plaza A,Muro A,et al.Synthesis and evaluation of some lipidic aminoalcohols and diamines as immunomodulators[J].Bioorg Med Chem Lett.2006;16(23):6091-5
[62]Hashimoto M,Asai Y,Tamai R,et al.Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide[J].FEBS Letters,2003;543(1-3):98-102.
[63]Viney JL.Dentritic cell subsets:the ultimate T cell differentiation decision makers[J]? Gut,1999;45(5):640-1.
[64]Horng T,Barton GM,Flavell RA,el al.The adaptor molecule TIRAP provides signaling specificity for Toil-like receptors[J].Nature,2002,;420:329-3.
[65]Casals C,Barrachina M,Serra M,el al.Lipopolysaccharide Up-Regulates MHC Class ⅡExpression on Dendritic Cells through an AP-1 Enhancer without Affecting the Levels of CIITA[J].J Immunol.2007;178(10):6307-15.
[66]den Haan JM,Kraal G,Bevan MJ.Cutting Edge:Lipopolysacchadde Induces IL-10-Producing Regulatory CD4+ T Cells That Suppress the CD8+ T Cell Response[J].J Immunol.2007 May 1;178(9):5429-33.
[1]Edelstein ML,Abedi MR,Wtxon J.Gene therapy clinical trials worldwide to 2007-an update[J].J Gene Med.2007;9(10):833-42.
[2]Kyrkanides S,Kambylafkas P,Miller JH,et al.The cranial base in craniofacial development:a gene therapy study[J].J Dent Res.2007;86(10):956-61.
[3]Muntoni F,Wells D.Genetic treatments in muscular dystrophies[J].Curr Opin Neurol.2007;20(5):590-4.
[4]Kent A,Oosterwijk C.A patient and family perspective on gene therapy for rare diseases[J].J Gene Med.2007;9(10):922-3.
[5]Mulavisala P,Vuylsteke A,Latimer R.Gene therapy in the management of cardiovascular diseases[J].Ann Card Anaesth.2001;4(1):4-6.
[6]Ito MK.ISIS 301012 gene therapy for hypercholesterolemia:sense,antisense,or nonsense?[J]Ann Pharmacother.2007;41(10):1669-78.
[7]Rodino-Klapac LR,Chic0ine LG,Kaspar BK,et al.Gene therapy for duchenne muscular dystrophy:expectations and challenges[J].Arch Neurol.2007;64(9):1236-41.
[8]Tdppel S,Cucchiarini M,Madry H,et al.Gene therapy for articular cartilage repair[J].Proc Inst Mech Eng[H].2007;221(5):451-9.
[9]Kanerva A,Raki M,Hemminki A.Gene therapy of gynaecological diseases[J].Expert Opin Biol Ther.2007;7(9):1347-61.
[10]Mills JN,Dall′era JE,Carlsen SN,et al.Gene therapy for erectile dysfunction[J].Pharmacogenomics.2007;8(8):979-84.
[11]Douglas JT.Adenoviral vectors for gene therapy[J].Mol Biotechnol.2007;36(1):71-80.
[12]Rehman KK,Bertera S,Trucco M,et al.Immunomodulation by adenoviral-mediated SCD40-Ig gene therapy for mouse allogeneic islet transplantation[J]. Transplantation.2007;84(3):301-7.
[13]Lamartina S,Cimino M,Roscilli G,et al.Helper-dependent adenovirus for the gene therapy of proliferative retinopathies:stable gene transfer,regulated gene expression and therapeutic efficacy[J].J Gene Med.2007;9(10):862-74
[14]Xu Y,Darcy PK,Kershaw MH.Tumor-specific dendritic cells generated by genetic redirection of Toll-like receptor signaling against the tumor-associated antigen,erbB2[J].Cancer Gene Ther.2007;14(9):773-80.
[15]Tatsumi T,Takehara T,Yamaguchi S,et al.Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity[J].Gene Ther.2007;14(11):863-71.
[16]Cheng C,Gall JG,Kong WP,et al.Mechanism of ad5 vaccine immunity and toxicity:fiber shaft targeting of dendritic cells[J].PLoS Pathog.2007;3(2):e25.
[17]Tomihara K,Kato K,Masuta Y,et al.Gene transfer of the CD40-1igand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells[J].Int J Cancer.2007;120(7):1491-8.
[18]Bontkes HJ,Kramer D,Ruizendaal JJ,et al.Dendritic cells transfected with intedeukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells[J].Gene Ther.2007;14(4):366-75.
[19]Kyte JA,Gaudemack G.Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells[J].Cancer Immunol Immunother.2006;55(11):1432-42.
[20]Harui A,Roth MD,Vira D,et al.Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of alpha(v)beta3 integrins[J].J Leukoc Biol.2006;79(6):1271-8.
[21]Yang SC,Batra RK,Hillinger S,et al.Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma[J].Cancer Res.2006;66(6):3205-13.
[22]Chinen J,Shearer WT.Advances in basic and clinical immunology in 2006[J].J Allergy Clin Immunol.2007 120(2):263-70..
[23]van Duin D,Shaw AC.Toll-like receptors in older adults.J Am Geriatr Soc.2007;55(9):1438-44.
[24]眭建,许化溪。TLRS与支气管炎症免疫细胞研究进展[J]。中国老年学杂志。2006:26(11):1589-1562
[25]Steinman RM,Hawiger D,Nussenzweig MC.Tolerogenic dendric cells.Annu Rev Immunol 2003;21:685-711
[26]Medzhitov R,Preston HP,Janeway CA.A human homologue cf the Drosophila Toll protein signals activation of adaptive immunity[J].Nature,1997;388(6640):394-7.
[27]Sehra S,Pynaert G,Toumoy K,et al.Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma[J].J Immunol,2003;171(4):2080-9.
[28]Viney JL.Dentritic cell subsets:the ultimate T cell differentiation decision makers[J]? Gut,1999;45(5):640-1.
[29]Homg T,Barton GM,Flavell RA,et al.The adaptor molecule TIRAP provides signaling specificity for Toil-like receptors[J].Nature,2002,;420:329-3.
[30]Horng T,Barlon GM,Medzhitov R.TIRAP:an adaptor molecule in the Toll signaling pathway [J].Nat hnmunol,2001,;2(9):835;41.
[31]Casals C,Barrachina M,Serra M,el al.Lipopolysaccharide Up-Regulates MHC Class ⅡExpression on Dendritic Cells through an AP-1 Enhancer without Affecting the Levels of CI1TA[J].J Immunol.2007;178(10):6307-15.
[32]den Haan JM,Kraal G,Bevan MJ.Cutting Edge:Lipopolysaccharide Induces IL-10-Producing Regulatory CD4+ T Cells That Suppress the CD8+ T Cell Response[J].J Immunol.2007 May 1;178(9):5429-33.
[33]Yamazaki S,Patel M,Harper A,et al.Effective expansion of alloantigen-specific Foxp3+CD25+CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.Proc Natl Acad Sci USA.2006;103(8):2758-2763
[1]Conway JE,Rhys CM,Zolotukhin I,et al.High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap[J].Gene Ther.1999;6(6):986-93.
[2]Miller N,Whelan J.Progress in transcriptionally targeted and regulatable vectors for genetic therapy[J].Hum Gene Ther.1997;8(7):803-15.
[3]Binley K,Iqball S,Kingsman A,et al.An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer[J].Gene Ther.1999;6(10):1721-7.
[4]Wolff JA,Herweijer H.Self-amplifying vectors for gene delivery[J].Adv Drug Deliv Rev.1997;27(1):5-16.
[5]Lieber A,Steinwaerder DS,Carlson CA,et al.Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes[J].J Virol.1999;73(11):9314-24.
[6]Johnston KM,Jacoby D,Pechan PA,et al.HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells[J].Hum Gene Ther.1997;8(3):359-70.
[7]Tan BT,Wu L,Berk AJ.An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency[J].J Virol.1999;73(9):7582-9.
[8]Caplen NJ,Higginbotham JN,Scheel JR,et al.Adeno-retroviral chimeric viruses as in vivo transducing agents[J].Gene Ther.1999;6(3):454-9.
[9]Krasnykh VN,Mikheeva GV,Douglas JT,et al.Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism[J].J Virol.1996;70(10):6839-46.
[10]Mosca PJ,Lyerly HK,Clay TM,et al.Dendritic cell vaccines[J].Front Biosci.2007;12:4050-60.
[11]udewig B,Ochsenbein AF,Odermatt B,et al.Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in sever autoimmune disease[J].J Exp Med,2001,191:795-804.
[12]Eriksson EM,Jackson DC.Recent advances with TLR2-targeting lipopeptide-based vaccines[J].Curr Protein Pept Sci.2007;8(4):412-7.
[13]Chinen J,Shearer WT.Advances in basic and clinical immunology in 2006[J].J Allergy Clin Immunol.2007;120(2):263-70.
[2]Vandenbulcke L,Bachert C,Van Cauwenberge P,et al.The innate immune system and its role in allergic disorders[J].Int Arch Allergy Immunol.2006;139(2):159-65.
[3]Lee CW,Matulonis UA,Castells MC.Carboplatin hypersensitivity:a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions[J].Gynecol Oncol.2004;95(2):370-6.
[4]唐深.TLR家族及其功能研究进展[J].微生物学免疫学进展,2004;32(2):42-5
[5]余玉明.TOLL样受体与移植免疫[J].国外医学移植与血液净化分册,2005;3(6):34-7
[6]Amati L,Pepe M,Passeri ME,Mastronardi ML,et al.,Covelli V.Toll-like receptor signaling mechanisms involved in dendritic cell activation:potential therapeutic control of T cell polarization[J].Curr Pharm Des.2006;12(32):4247-54.
[7]Tang C,Inman MD,van Rooijen N,et al.The type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism[J].J lmmunol.2001;166(3):1471-81.
[8]Akdis M,Trautmann A,Klunker S,et al.T helper(Th)2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Thl cells[J].FASEB J,2003;17(9):1026-35.
[9]Pai SY,Truitt ML,Ho IC.GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells[J].Proc Natl Acad Sci U S A,2004;101(7):1993-8.
[10]Pernis AB,Rothman PB.JAK-STAT signaling in asthma[J].J Clin Invest,2002;109(10):1279-83.
[11]Hofer T,Nathansen H,Lohning M,et al.GATA-3 transcriptional imprinting in Th2lymphocytes:A mathematical model[J].Proc Natil Acad Sci USA,2002;99(14):9364-8.
[12]Skapenko A,Lipsky PE,Kraetsch HG,et al.Antigen-Independent Th2 Cell Differentiation by Stimulation of CD28:Regulation Via IL-4 Gene Expression and Mitogen-Activated Protein Kinase Activation[J].J Immunol,2001;166(7):4283-92.
[13]Bueving HJ,van der Wouden JC.What is the role of virus vaccination in patients with asthma[J]? Curr Allergy Asthma Rep.2007;7(1):72-6
[14]Barton GM.Viral recognition by Toll-like receptors[J].Semin Immunol.2007;19(1):33-40.
[15]Kabelitz D.Expression and function of Toll-like receptors in T lymphocytes[J].Curr Opin Immunol.2007;19(1):39-45
[16]Kallinich T,Beier KC,Wahn U,et al.T-cell co-stimulatory molecules:their role in allergic immune reactions[J].Eur Respir J.2007;29(6):1246-55.
[17]Fedele G,Celestino I,Spensieri F,et al.Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response[J].Microbes Infect.2007 12;[Epub ahead of print]
[18]Uchida T,Scumpia PO,Murasko DM,et al.Variable requirement of dendritic cells for recruitment of NK and T cells to different TLR agonists[J].J Immunol.2007 15;178(6):3886-92
[19]Bauer S,Hangel D,Yu P.Immunobiology of toll-like receptors in allergic disease[J].Immunobiology.2007;212(6):521-33.
[20]Medzhitov R,Preston HP,Janeway CA.A human homologue cf the Drosophila Toll protein signals activation of adaptive immunity[J].Nature,1997;388(6640):394-7.
[21]Bell JK,Botos I,Hall PR,et al.The molecular structure of the TLR3 extracellular domain[J].J Endotoxin Res.2006;12(6):375-8.
[22]Delneste Y,Beauvillain C,Jeannin P.Innate immunity:structure and function of TLRs[J].Med Sci.2007;23(1):67-73.
[23]Mayer AK,Muehmer M,Mages J,et al.Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells[J].J Immunol.2007;178(5):3134-42.
[24]Sukkar MB,Xie S,Khorasani NM,et al.Toll-like receptor 2,3,and 4 expression and function in human airway smooth muscle[J].J Allergy Clin Immunol.2006;118(3):641-8
[25]Komiya A,Nagase H,Okugawa S,et al.Expression and function of toll-like receptors in human basophils[J].Int Arch Allergy Immunol.2006;140 Suppl 1:23-7.
[26]Sugawara Y,Uehara A,Fujimoto Y,et al.Toll-like receptors,NOD1,and NOD2 in oral epithelial cells[J].J Dent Res.2006;85(6):524-9.
[27]Remer KA,Brcic M,Sauter KS,et al.Human monocytoid cells as a model to study Toll-like receptor-mediated activation[J].J Immunol Methods.2006 Jun 30;313(1-2):1-10.
[28]Kumar A,Yu FS.Toll-like receptors and corneal innate immunity[J].Curr Mol Med.2006;6(3):327-37.
[29]Spachidou MP,Bourazopoulou E,Maratheftis CI,et al.Expression of functional Toll-like receptors by salivary gland epithelial cells:increased mRNA expression in cells derived from patients with primary Sjogren's syndrome[J].Clin Exp lmmunol.2007;147(3):497-503.
[30]Carlo E,Rosenberg IM,Brandwein SL,et al.Lipopolysaccharide activate distinct signaling pathways in intestinal epithelial cell lines expressing Toll like receptors[J].J Immunol,2000;164(2):966-72.
[31]Frantz S,Kobzik L,Kim YD,et al.TLR4 expression in cardiac myocytes in normal and failing myocardium[J].J Clin Invest,1999;104(3):271-80
[32]Arbour NC,Lorenz E,Schutte BC,et al.TLR4 mutation are association witt endotoxin hyporesponsiveness in humans[J].Blat Genet,2000;25(2):187-91.
[33]Su GL,Klein RD,Aminlari A,et al.Kupffer cell activation by lipopolysaccharide in rats:role for !ipopolysaccharide binding protein an,toil-like receptor 4[J].Hepatology,2000;31(4):934-6.
[34]Chow JC,Young DW,Golenbock DT,et al.ToiF!ike recepor-4 mediate,lipopolysa～charideinduced signal tmnsduction[J].J Biol Chem,1999;27(16):10689-92.
[35]Lin Y,Lee H,Berg AH,et al.The lipopolysaecharide-activited toll like receptor4 induces synthesis of the dosely related receptor TLR-2 in adipocyte[J].J Biol Chem,2000;275(32):24255-63.
[36]Nomura F,Akashi S,Sakao Y,et al.Endotoxin tolenrance in mouce peritoneal macrophage correlates with down-regulation of surface toll-lik receptor 4 expression[J].J Immunoi,2000,164(7):3476-79.
[37]Kleeberger SR,Reddy S,Zhang LY,et al.Genetic susceptibility to ozone-induced lung hyperlneability:role of toil- like receptor 4[J].Am J Respir Cell Md Bid,2000;22(5):620-7.
[38]Medzhitov R.TLR-mediated innate immune recognition[J].Semin Immunol.2007;19(1):1-2.
[39]Kawai T,Akira S.TLR signaling[J].Semin Immunol.2007;19(1):24-32.
[40]Akashi-Takamura S,Miyake K.Toll-like receptors(TLRs)and immune disorders[J].J Infect Chemother.2006;12(5):233-40
[41]Kaisho T,Akira S.Toll-like receptor function and signaling[J].J Allergy Clin Immunol.2006;117(5):979-87
[42]Wang J,Shao Y,Bennett TA,et al.The functional effects of physical interactions among Toll-like receptors 7,8,and 9[J].J Biol Chem.2006;281(49):37427-34.
[43]Johnson GB,Brunn GJ,Tang AH,et al.Evolutionary dues to the functions of the Toil-like family as surveillance receptors[J].Trends.Immunol,2003;24(1):19-24.
[44]Wagner H.Endogenous TLR ligands and autoimmunity[J].Adv Immunol.2006;91:159-73.
[45]Taylor RC,Richmond P,Upham JW.Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen[J].J Allergy Clin Immunol.2006;117(5):1148-54.
[46]Johansen P,Senti G,Martinez Gomez JM,et al.Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy[J].Clin Exp Allergy.2005;35(12):1591-8.
[47]Huang B,Zhao J,Shen S,et al.Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling[J].Cancer Res.2007;67(9):4346-52.
[48]Homg T,Barton GM,Flavell RA,et al.The adaptor molecule TIRAP provides signaling specificity for Toil-like receptors[J].Nature,2002,;420:329-3.
[49]Homg T,Barlon GM,Medzhitov R.TIRAP:an adaptor molecule in the Toll signaling pathway [J].Nat hnmunol,2001,;2(9):835;41.
[50]Carmody RJ,Chen YH.Nuclear factor-kappaB:activation and reguation during toll-like receptor signaling[J].Cell Mol Immunol.2007;4(1):31-41.
[51]Purcell MK,Smith KD,Hood L,et al.Conservation of Toll-Like Receptor Signaling Pathways in Teleost Fish[J].Comp Biochem Physiol Part D Genomics Proteomics.2006;1(1):77-88.
[52]Lemmers B,Salmena L,Bidere N,et al.Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling[J].J Biol Chem.2007 Mar 9;282(10):7416-23.Epub 2007 Jan 9.
[53]Fitzgerald KA,Chen ZJ.Sorting out Toll signals[J].Cell.2006 2;125(5):834-6.
[54]Oda K,Kitano H.A comprehensive map of the toll-like receptor signaling network[J].Mol Syst Biol.2006;2:2006.0015.
[55]Akira S.TLR signaling[J].Curr Top Microbiol Immunol.2006;311:1-16
[56]Pandey S,Agrawal DK.Immunobiology of Toll-like receptors:emerging trends[J].Immunol Cell Biol.2006;84(4):333-41.
[57]Bachar O,Adner M,Uddman R,et al.Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin,an effect mediated by JNK and NF-kappa B signaling pathways[J].Eur J Immunol.2004;34(4):1196-207.
[58]Wang J,Wang X,Hussain S,et al.Distinct Roles of Different NF-{kappa}B Subunits in Regulating Inflammatory and T Cell Stimulatory Gene Expression in Dendritic Cells[J].J Immunol.2007;178(11):6777-88.
[59]Carmody RJ,Chert YH.Nuclear factor-kappaB:activation and regulation during toll-like receptor signaling[J].Cell Mol Immunol.2007;4(1):31-41
[60]Doyle SL,O'Neill LA.Toll-like receptors:from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity[J].Biochem Pharmacol.2006;72(9):1102-13.
[61]Qian C,An HZ.The effects and their mechanism study of TLRs in adaptability immunity[J].Foreign Meical Sciences Section of Immunology,2005:28(1):16-9
[62]Imanishi T,Hara H,Suzuki S,et al.Cutting Edge:TLR2 Directly Triggers Thl Effector Functions[J].J Immunol.2007;178(11):6715-9
[63]Imanishi T,Hara H,Suzuki S,et a/.Cutting Edge:TLR2 directly triggers Th1 effector functions.J Immunol.2007;178(11):6715-9.
[64]Bekeredjian-Ding I,Roth SI,Gilles S,et al.T cell-independent,TLR-induced IL-12p70production in primary human monocytes[J].J Immunol.2006 Jun 15;176(12):7438-46.
[65]Sutmuller RP,Morgan ME,Netea MG,et al.Toll-like receptors on regulatory T cells:expanding immune regulation[J].Trends Immunol.2006;27(8):387-93
[66]Homer AA.Update on toll-like receptor ligands and allergy:implications for immunotherapy[J].Curr Allergy Asthma Rep.2006;6(5):395-401.
[67]Camateros P,Tamaoka M,Hassan M,et al.Chronic Asthma Induced Airway Remodeling is Prevented by the Toll-like Receptor 7/8 Ligand $28463[J].Am J Respir Crit Care Med.2007;[Epub ahead of print]
[68]Shan X,Hu A,Veler H,et al.Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling[J].Am J Physiol Lung Cell Mol Physiol.2006;291(3):L322-3.
[69]Fedele G,Celestino I,Spensieri F,et al.Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response[J].Microbes Infect.2007;9(7):855-63.
[70]Su MS.TLRs and.immunological regulation of asthma[J].Foreign Meical Sciences Section of Pediatrics,2005;32(2):92-5
[71]Nigo YI,Yamashita M,Hirahara K,et al.Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function[J].Proc Natl Acad Sci U S A.2006;103(7):2286-91
[72]Nigo YI,Yamashita M,Hirahara K,et al.Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function[J].Proc Nail Acad Sci U S A.2006;103(7):2286-91.
[73]Pawankar R.Mast cells in allergic airway disease and chronic rhinosinusitis[J].Chem Immunol Allergy.2005;87:111-29.
[74]梁峰 胡大一 王伯瑶.Toll样受体-4在人肺腺上皮细胞、单核细胞和脐静脉血管内皮细胞的表达[J].山西医科大学学报,2004;35(2);101-3
[75]万幸,王培训,周联.脂多糖刺激前后小鼠肺肝脾组织中Toll样等受体基因表达情况[J].中国危重病急救医学.2004;16(2):73-6
[76]Samarasinghe R,Tailor P,Tamura T,et al.Induction of an anti-inflammatory cytokine,IL-10,in dendritic cells after toll-like receptor signaling[J].J Interferon Cytokine Res.2006;26(12):893-900.
[77]Bhattacharjee RN,Akira S.Modifying toll-like receptor 9 signaling for therapeutic use[J].Mini Rev Med Chem.2006;6(3):287-91.
[78]Ritter M,Mennedch D,Weith A,et al.Characterization of Toll-like receptors in primary lung epithelial cells:strong impact of the TLR3 ligand poly(I:C)on the regulation of Toll-like receptors,adaptor proteins and inflammatory response[J].J Irfflamm(Lond).2005;2(1):16-20
[79]Greene CM,McElvaney NG.Toll-like receptor expression and function in airway epithelial cells[J].Arch Immunol Ther Exp(Warsz).2005;53(5):418-27
[80]Mayer AK,Muehmer M,Mages J,et al.Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells[J].J Immunol.2007;178(5):3134-42.
[81]Bemdt A,Derksen FJ,Venta PJ,et al.Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction[J].Am J Physiol Lung Cell Mol Physiol.2007;292(4):L936-43.
[82]Schmeck B,Huber S,Moog K,et al.Pneumococci induced TLR- and Racl-dependent NF-kappaB-recruitment to the IL-8 promoter in lung epithelial cells[J].Am J Physiol Lung Cell Mol Physiol.2006;290(4):L730-L737
[83]Hauber I-IP,Tulic MK,Tsicopoulos A,et al.Toll-like receptors 4 and 2 expression in the bronchial mucosa of patients with cystic fibrosis[J]..Can Respir J.2005 Jan-Feb;12(1):13-8.
[84]Hertz CJ,Wu Q,Porter EM,et al.Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2[J].J Immunol.2003Dec 15;171(12):6820-6.
[85]Becker MN,Diamond G,Verghese MW,et al.CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium[J].J Biol Chem.2000 Sep 22;275(38):29731-6.
[86]Pandey S,Agrawal DK.Immunobiology of Toll-like receptors:emerging trends[J].Immunol Ceil Biol.2006;84(4):333-41.
[87]Radhakrishnan S,Wiehagen KR,Pulko V,et al.Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells:dependence on TCR:peptide-MHC interaction,ICAM-1,IL-12,and IFN-gamma[J].J Immunol.2007 15;178(6):3583-92.
[88]Marsland BJ,Nembrini C,Griin K,et al.TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myoearditis[J].J Immunol.2007 Mar 15;178(6):3466-73.
[89]Kabelitz D,Wesch D,Oberg HH.Regulation of regulatory T cells:role of dendritic cells and toll-like receptors[J].Crit Rev Imrnunol.2006;26(4):291-306.
[90]Arnati L,Pepe M,Passeri ME,et al.Toll-like receptor signaling rneehanisms involved in dendritic cell activation:potential therapeutic control of T cell polarization[J].Curr Pharm Des.2006;12(32):4247-54.Review.
[91]Medzhitov R,Preston HP,Janeway CA.A human homologne ef the Drosophila Toil protein signals activation of adaptive immunity[J].Nature,1997;388(6640):394-7.
[92]Sehra S,Pynaert G,Toumoy K,et al.Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma[J].J Imrnunol,2003;171(4):2080-9.
[93]Viney JL.Dentritie cell subsets:the ultimate T cell differentiation decision makers[J]? Gut,1999;45(5):640-1.
[94]Terhorst D,Kalali BN,Weidinger S,et al.Monoeyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands[J].Clin Exp Allergy.2007;37(3):381-90.
[95]Demedts IK,Braeke KR,Maes T,et al.Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms[J].Am J Respir Cell Mol Biol.2006;35(3):387-93.
[96]Watts C,Zaru R,Prescott AR,et al.Proximal effects of Toll-like receptor activation in dendritic cells[J].Curr Opin Immunol.2007;19(1):73-8.
[97]Xu L.Toll like protein[J].Chemistry Of Life,2003;23(1):36-8
[98]Hubert FX,Voisine C,Louver C,et al.Josien R.Differential pattemrecognition receptor expression but stereotyped responsiveness in rat spleen dendritic cell subsets[J].J Immunol.2006;177(2):1007-16.
[99]Zhou AM,Feng J.Study on Toll like receptor differentiation of DC and signal transduction[J].Chin J Derm Venereol,2004;18(4):246-7
[100]Yang IA,Fong KM,Holgate ST,Holloway JW.The role of Toll-like receptors and related receptors of the innate immune system in asthma[J].Curr Opin Allergy Clin Immunol.2006;6(1):23-8
[101]Duez C,Gosset P,Tonnel AB.Dendritic cells and toll-like receptors in allergy and asthma[J].Eur J Dermatol.2006;16(1):12-6
[102]Redecke V,Hacker H,Datta SK,et al.Cutting edge:activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma[J].J Immunol.2004;172(5):2739-43
[103]Eisenbarth SC,Piggott DA,Huleatt JW,et al.Lipopolysaccharide-enhanced,toil-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen[j].J Exp Med.2002;196(12):1645-51.
[104]Ishii KJ,Uematsu S,Akira S.Toll' gates for future immunotherapy[J].Curt Pharm Des.2006;12(32):4135-42.
[105]Hoebe K,Jiang Z,Georgel P,et al.TLR signaling pathways:opportunities for activation and blockade in pursuit of therapy[J].Curt Pharm Des.2006;12(32):4123-34.
[106]Rezaei N.Therapeutic targeting of pattern-recognition receptors[J].Int Immunopharmacol.2006;6(6):863-9.
[107]Hayashi T,Raz E.TLR9-based immunotherapy for allergic disease[J].Am J Med.2006;119(10):897.e1-6.
[108]Bhattacharjee RN,Akira S.Modifying toll-like receptor 9 signaling for therapeutic use.Mini Rev Med Chem.2006 Mar;6(3):287-91.Modifying toll-like receptor 9 signaling for therapeutic use[J].Mini Rev Med Chem.2006;6(3):287-91.
[109]Cairns B,Maile R,Barnes CM,Frelinger JA,et al.Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after bum injury[J].J Trauma.2006;61(2):293-8
[110]Homer AA.Update on toll-like receptor ligands and allergy:implications for immunotherapy[J].Curr Allergy Asthma Rep.2006;6(5):395-401.
[111]Galdeano CM,Perdigon G.The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity[J].Clin Vaccine Immunol.2006;13(2):219-26.
[112]Dugas B,Mercenier A,Lenoir-Wijnkoop I.Immunity and Probioties[J].Immunol Today,1999,20(9):387-390.
[113]Yoshimura A,Lien E,Ingalls RR.Cutting edge:recognition of Gram-positive bacterial cell wall components by the innate immune systemoccurs via Toll-like receptor 2[J].J Immunol,1999,163(1):1-5.
[114]Rachmilewitz D,Katakura K,Karmeli F,et al.Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis[J].Gastroenterology.2004;126(2):520-8.
[115]Lee J,Rachmilewitz D,Raz E.Homeostatic effects of TLR9 signaling in experimental colitis[J].Ann N Y Acad Sci.2006;1072:351-5.
[116]Rachmilewitz D,Katakura K,Karmeli F,et al.Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis[J].Gastroenterology.2004;126(2):520-8.
[117]Hu X,Paik PK,Chert J,et al.IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins[J].Immunity.2006;24(5):563-74.
[118]Martin M,Rehani K,Jope RS,et al.Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3[J].Nat Immunol.2005;6(8):777-84.
[1]Karoly E,Fekete A,Banki NF,et al.Heat shock protein 72(HSPAIB)Gene Polymorphism and toll-like receptor(TLR)4 mutation are associated with increased risk of urinary tract infection in children[J].Pediatr Res.2007;61(3):371-4.
[2]Cheng I,Plummer S J,Casey G,et al.Toll-like receptor 4 genetic variation and advanced prostate cancer risk[J].Cancer Epidemiol Biomarkers Prey.2007;16(2):352-5.
[3]Jung YO,Cho ML,Kang CM,et al.Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts.Immunol[J].Lett.2007;109(1):21-7.
[4]Arbour NC,Lorenz E,Schutte BC,et al.TLR4 mutation are association with endotoxin hyporesponsiveness in humans[J].Nat Genet,2000;25(2):187-191.
[5]Kleeberger SR,Reddy S,Zhang LY,et al.Genetic susceptibility to ozone-induced lung hypermeability:role of toll-like receptor 4[J].AmJ Respir Cell Mol Biol,2000,22(5):620-627.
[6]Chow JC,Young DW,Golenbock DT,et al.Toll-like recepor 4 mediates lipopolysaccharide induced signal transduction[J].J Biol Chem,1999;274(16):10689-10692.
[7]Nomura F,Akashi S,Sakao Y,et al.Endotoxin tolenrance in mouce peritoneal macrophage correlates with down-regulation of surface toll-like receptor 4 expression[J].J Immunol,2000,164(7):3476-3479.
[8]Su GL,Klein RD,Aminlari A,et al.Kupffer cell activation by lipopolysaecharide in rats:role for lipopolysaecharide binding protein and toll-like receptor 4[J].Hepatology,2000,31(4):934-936.
[9]Lin Y,Lee H,Berg AH,et al.The lipopolysaccharide2activited toll-like receptor-4 induces synthesis of the closely related receptor TLR22 in adipocyte[J].J Biol Chem,2000,275(32):24255-24263.
[10]Cario E,Rosenberg IM,Brandwein SL,et al.Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors[J]J Immunol,2000,164(2):966-972.
[11]Frantz S,Kobzik L,Kirn YD,et al.TLR4 expression in cardiac myocytes in normal and failing myocardium[J].J Clin Invest,1999,104(3):271-280.
[12]Rodriguez D,Keller AC,Faquim-Mauro EL,et al.Bacterial lipopolysaecharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2activity[J].J Immunol,2003,17(2):1001-1008.
[13]Kurt-Jones EA,Popova L,Kwinn L,et al.Pattern recognition receptors TLR4 and CD14mediate response to respiratory syncytial vires[J].Nat Immunol,2000;1(5):398-401.
[14]EisenbarthSC,PiggottDA,HuleattJW,et al.Lipopolysaecharide-enhanced,toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen[J].J ExpMed,2002,16,196(12):1645-1651.
[15]Erddge C,Moncayo-Nieto OL,Morgan R,et al.Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[16]Duez C,Gosset P,Tonnel AB.Dendritic cells and toll-like receptors in allergy and asthma[J].Eur J Dermatol.2006;16(1):12-6.
[17]Poltorak A,He X,Smimova I,et al.Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in Tlr4 gene[J].Science.1998;282(5396):2085-8.
[18]Okayama N,Fujimura K,Suehiro Y,et al.Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness[J].J Clin Lab Anal.2002;16(1):56-8.
[19]En-idge C,Moncayo-Nieto OL,Morgan R,et al.Acinetobacter baumannii activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[20]Puthothu B,Forster J,Heinzmann A,et al.TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease[J].Dis Markers.2006;22(5-6):303-8
[21]Barber RC,Aragaki CC,Rivera-Chavez FA,et al.TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following bum injury[J].J Med Genet.2004;41(11):808-13.
[1]Osten P,Grinevich V,Cetin A.Viral vectors:a wide range of choices and high levels of service.Handb Exp Pharmacol[J].2007;178:177-202
[2]Yotnda P,Savoldo B,Charlet-Berguerand N,et al.Targeted delivery of adenoviral vectors by cytotoxic T cells[J].Blood.2004;104(8):2272-80.
[3]Kang BN,Deshpande DA,Tirumurugaan KG,et al.Adenoviral mediated anti-sense CD38attenuates TNF-alpha-induced changes in calcium homeostasis of human airway smooth muscle cells[J].Call J Physiol Pharmacol.2005;83(8-9):799-804.
[4]Mancheno-Corvo P,Martin-Duque P.Viral gene therapy[J].Clin Transl Oncol.2006;8(12):858-67.
[5]Erridge C,Moncayo-Nieto OL,Morgan R,et al.Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[6]Duez C,Gosset P,Tonnel AB.Dendritic cells and toll-like receptors in allergy and asthma[J].Eur J Dermatol.2006;16(1):12-6.
[7]Okayama N,Fujimura K,Suehiro Y,et al.Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness[J].J Clin Lab Anal.2002;16(1):56-8.
[8]Erridge C,Moncayo-Nieto OL,Morgan R,et al.Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[9]Puthothu B,Forster J,Heinzmann A,et al.TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease[J].Dis Markers.2006;22(5-6):303-8
[10][10]Barber RC,Aragaki CC,Rivera-Chavez FA,et al.TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury[J].J Med Genet.2004;41(11):808-13.
[11]裴丽红,刘祝公,陈慰峰。小鼠胸腺树突状细胞系的克隆化及基本鉴定[J]。中国免疫学杂志。1999;15(6):257-9
[12]Graham FL,Prevec L.Methods for construction of adenovirus vectors[J].Mol Biotechnol.1995;3(3):207-20.
[13]Li X,Fan R,Zou X,Gao L,et al.Inhibitory effect of recombinant adenovirus carrying immunocaspase-3 on hepatocellular carcinoma[J].Biochem Biophys Res Commun.2007;358(2):489-94.
[14]Pyles RB,Warnick RE,Chalk CL,et al.A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors[J].Hum Gene Ther.1997 Mar 20;8(5):533-44.
[15]Kramm CM,Chase M,Herrlinger U,et al.Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy[J].Hum Gene Ther.1997;8(17):2057-68.
[16]Collaco RF,Cao X,Trempe JP.A helper virus-free packaging system for recombinant adeno-associated virus vectors[J].Gene.1999;238(2):397-405.
[17]Grimm D,Kern A,Rittner K,Kleinschmidt JA.Novel tools for production and purification of recombinant adenoassociated virus vectors[J].Hum Gene Ther.1998;9(18):2745-60.
[18]Kreppel F,Gackowski J,Schmidt E,et al.Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors[J].Mol Ther.2005;12(1):107-17.
[19]Sakurai F,Mizuguchi H,Yamaguchi T,et al.Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector[J].Mol Ther.2003;8(5):813-21
[20]Kostense S,Koudstaal W,Sprangers M,et al.Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector[J].AIDS.2004 21;18(8):1213-6.
[21]Karoly E,Fekete A,Banki NF,et al.Heat shock protein 72(HSPA1B)Gene Polymorphism and toll-like receptor(TLR)4 mutation are associated with increased risk of urinary tract infection in children[J].Pediatr Res.2007;61(3):371-4.
[22]Cheng I,Plummer SJ,Casey G,et al.Toll-like receptor 4 genetic variation and advanced prostate cancer risk[J].Cancer Epidemiol Biomarkers Prev.2007;16(2):352-5.
[23]Jung YO,Cho ML,Kang CM,et al.Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts[J].Immunol Lett.2007;109(1):21-7.
[24]Okayama N,Fujimura K,Suehiro Y,et al.Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness[J].J Clin Lab Anal.2002;16(1):56-8.
[25]Erridge C,Moncayo-Nieto OL,Morgan R,,et al.Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling[J].J Med Microbiol.2007;56(Pt 2):165-71.
[26]Puthothu B,Forster J,Heinzmann A,et al.TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease[J].Dis Markers.2006;22(5-6):303-8
[27]Barber RC,Aragaki CC,Rivera-Chavez FA,et al.TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following bum injury[J].J Med Genet.2004;41(11):808-13.
[1]Ueno H,Klechevsky E,Morita R,et al.Dendritic cell subsets in health and disease[J].Immunol Rev.2007;219(1):118-42.
[2]曹雪涛.树突状细胞与肿瘤的免疫治疗和基因治疗[J].中国肿瘤生物治疗杂志,1998;5(2):82-84.
[3]Banchereau J,Steinman R M.Dendritic cells and the control of immunity[J].Nature,1998;392(6673):245-252.
[4]Steinman R M,Pope M.Exploiting dendritic cells to improve vaccine ef-ficacy[J].J Clin Invest J,2002;109(12):1519-1526.
[5]Caux C,Massacri C,Vanbervliet B,et al.CD34+ Hematopoietic Progen-itors FromHuman Cord Blood Differentiate AlongTwo Independent Den-dfitic Cell Pathways in Response to Granulocyte-Macrophage Colony-Stimulating Factor Plus Tumor Necrosis Factor:Ⅱ.Functional Analysis[J].J Blood,1997;90(4):1458-1470.
[6]Rouard H,Leon A,Klonjkowski B,et al.Adenoviral transduction of hu-man'clinical grade'immuature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity[J].J Immunol Method B,2000;241(1-2):69-81.
[7]曹雪涛,叶天星.树突状细胞研究在免疫学中的意义及其发展趋势[J].国外医学·免疫学分册,1998:21(6):281-285.
[8]Anita Reddy,Mark Sapp,Mary Feldman,et al.A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Ter-minal Maturation of Human Dendritic cells[J].JBlood,1997;90(9):3641-3646.
[9]吴松泉.细胞免疫中共刺激分子研究进展[J].国外医学·免疫学分册,2000;23(1):16-18.
[10]Mosca PJ,Lyerly HK,Clay TM,et al.Dendritic cell vaccines[J].Front Biosci.2007;12:4050-60.Review.
[11]Awasthi S.Dendritic cell- based vaccine against Coccidioides infection[J].Ann N Y Acad Sci.2007;[Epub ahead of print]
[12]hang S,Wang Q,Miao B.Review:dendritic cell-based vaccine in the treatment of patients with advanced melanoma[J].Cancer Biother Radiopharm,2007;22(4):501-7.
[13]Moiseyenko V,Imyanitov E,Danilova A,et al.Cell technologies in immunotherapy of cancer [J].Adv Exp Med Biol.2007;601:387-93.
[14]Ranieri E,Gigante M,Storkus WJ,et al.Translational mini-review series on vaccines:Dendritic cell-based vaccines in renal cancer[J].Clin Exp Immunol.2007;147(3):395-400.Review.
[15]Pal C,Ganguly D,Paul K,Pal S.Dendritic cells and antigen trapping technology--a revolution in vaccine/immunotherapy strategy[J].Indian J Exp Biol.2007;45(6):491-504.Review.
[16]Kugler A,Stuhler G,Walden P.Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hy-bdds[J].Nat Med,2000;6(3):332-336.
[17]Murphy GP,Tjon BA,Simmons SJ,et al.Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides:a phase Ⅱ prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease[J].Prostate,1999;38(1):73-78.
[18]Ashley DM,Faiola B,Nair S,et al.Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immu-nity against central nervous system tumors[J].J ExpMed,1997;186(7):1177-1182.
[19][19]Ojima T,Iwahashi M,Nakamura M,et al.Benefits of gene tra nsduction of granulocyte macrophage colony-stimulating facto r in cancer vaccine using genetically modified dendritic cells[J].Int J Oncol.2007;31(4):931-9.
[20]Ovali E,Dikmen T,Sonmez M,et al.Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine:a safety study[J].J Exp Clin Cancer Res.2007;26(2):209-14.
[21]Ishida T,Chada S,Stipanov M,et al.Dendritic cells transduced with wild-type p53gene elicit potent anti-tumour immune respo nses[J].Clin Exp Immunol,1999;117(2):244-251.
[22]Melero I,Duarte M,Ruiz J,et al.Intratumoral injection of bone-mar-row derived dendritic cells engineered to produce intedeukin-12in-duces complete regression of established murine transplantable colon adenocarcinomas[J].Gene Ther,1999;6(10):1779-1784.
[23]Perez-Diez A,Marincola FM.Immunotherapy against anti-genie tu-mors:a game with a lot of players.Cell Mol Life Sci,2002;59(2):230-240.
[24]van Duin D,Shaw AC.Toll-like receptors in older adults.J Am Geriatr Soc.2007;55(9):1438-44.
[25]Chinen J,Shearer WT.Advances in basic and clinical immunologyin 2006.J Allergy Clin Immunol.2007;120(2):263-70.
[1]Bharadwaj AS,Bewtra AK,Agrawal DK.Dendritic cells in allergic airway inflammation[J].Can J Physiol Pharmacol.2007;85(7):686-699.
[2]Aiba S.Dendritic cells-importance in allergy[J].Allergol Int.2007;56(3):201-8.
[3]Shinohara ML,Cantor H.The bridge between dendritic cells and asthma[J].Nat Med.2007;13(5):536-8.
[4]Kuipers H,Heirman C,Hijdra D,et al.Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2sensitization[J].J Leukoc Biol.2004;76(5):1028-38.
[5]Holt PG,Upham JW.The role of dendritic cells in asthma[J].Curr Opin Allergy Clin Immunol.2004;4(1):39-44.
[6]Weber-Chrysochoou C,Crisafulli D,Almqvist C,et al.for the Childhood Asthma Prevention Study Investigators.IL-5 T-cell responses to house dust mite are associated with the development of allergen-specific IgE responses and asthma in the first 5 years of life[J].J Allergy Clin Immunol.2007;120(2):286-92.
[7]Khor YH,Feltis BN,Reid DW,et al.Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction[J].Clin Exp Allergy.2007;37(8):1189-98.
[8]Homg T,Barton GM,Flavell RA,et al.The adaptor molecule TIRAP provides signaling specificity for Toil-like receptors[J].Nature,2002,;420:329-3.
[9]Homg T,Barlon GM,Medzhitov R.TIRAP:an adaptor molecule in the Toll signaling pathway [J].Nat hnmunol,2001;2(9):835;41.
[10]Carmody RJ,Chen YH.Nuclear factor-kappaB:activation and regulation during toll-like receptor signaling[J].Cell Mol Immunol.2007;4(1):31-41.
[11]Purcell MK,Smith KD,Hood L,et al.Conservation of Toll-Like Receptor Signaling Pathways in Teleost Fish[J].Comp Biochem Physiol Part D Genomics Proteomics.2006;1(1):77-88.
[12]Lemmers B,Salmena L,Bidere N,et al.Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling[J].J Biol Chem.2007;282(10):7416-23.
[13]Fitzgerald KA,Chen ZJ.Sorting out Toll signals[J].Cell.2006 2;125(5):834-6.
[14]Oda K,Kitano H.A comprehensive map of the toll-like receptor signaling network[J].Mol Syst Biol.2006;2:2006-15.
[15]Akira S.TLR signaling[J].CurrTop Microbiol Immunol.2006;311:1-16
[16]Pandey S,Agrawal DK.Immunobiology of Toll-like receptors:emerging trends[J].Immunol Cell Biol.2006;84(4):333-41.
[17]Bachar O,Adner M,Uddman R,et al.Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin,an effect mediated by JNK and NF-kappa B signaling pathways[J].Eur J Immunol.2004;34(4):1196-207.
[18]Wang J,Wang X,Hussain S,et al.Distinct Roles of Different NF-{kappa}B Subunits in Regulating Inflammatory and T Cell Stimulatory Gene Expression in Dendritic Cells[J].J Immunol.2007;178(11):6777-88.
[19]Carmody RJ,Chen YH.Nuclear factor-kappaB:activation and regulation during toll-like receptor signaling[J].Cell Mol Immunol.2007;4(1):31-41
[20]Doyle SL,ONeill LA.Toll-like receptors:from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity[J].Biochem Pharmacol.2006;72(9):1102-13.
[21]DABBAGH K,DAHL ME,LEWlS DB.Toll-like Receptor 4is Required for Optimal Development of Th2 Immune Response:role of Dent ritic Cells[J].J Immunol,2002;168(9):4524-4530.
[22]KUIPERS H,HIJDRA D,DE VRIES VC,et al.Lipopolysac- charide Induced Suppression of Airway Th2 Reponses doesnot Require IL-12 Production by Dent ritic Cells[J].J Immunol,2003;171(7):364523654.
[23]EISENBARTH SC,PIGGOT DA,HUL EATT JW,et al.Lipopolysaccharide Toll-like Receptor 4-Dependent T Helper Cell Type 2 Responses to Inhaled Antigen[J].J Exp Med,2002;196(12):164521651.
[24]CARAMAL HO I,LOPES-CARVAL HO T,OSTLER D,et al.Reguratory T Cells Selectively Express Toll-like Receptors and are Activated by Lipopolysacchadde[J].J Exp Med.2003;197(4):4032411.
[25]RESCIGNO M,URBANO M,RIMOLDI M,et al.Toll-like Receptor 4 is not Required for the Full Maturation of Dent ritic Cells or for t he Degradation of Gram-negative Bacteria[J].Surg Today.2007;37(10):867-73
[26]Ueno A,Murasaki K,Hagiwara N,el al.Increases in circulating T lymphoeytes expressing HLA-DR and CD40 ligand in patients with dilated cardiomyophthy[J].Heart Vessels.2007;22(5):316-21.
[27]Richards KA,Chaves FA,Krafcik FR,el al.Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DRl-restricted CD4 T-cell response to influenza virus hemagglutinin[J].J Virol.2007;81(14):7608-19.
[28]Wozniacka A,Lesiak A,Narbutt J,el al.Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus[J].Lupus.2007;16(2):89-94.
[29]Stewart R,Wei W,Challa A,el al.CD154 Tone Sets the Signaling Pathways and Transcdptome Generated in Model CD40-Pluricompetent L3055 Burkitt's Lymphoma Cells[J].J Immunol.2007;179(5):2705-12.
[30]Tousoulis D,Antoniades C,Nikolopoulou A,el al.Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes[J].Eur J Clin Invest.2007;37(8):623-8.
[31]Toutirais O,Gervais A,Cabillic F,el al.Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro[J].Clin Exp Immunol.2007;149(2):372-7.
[32]Thomas GR,Wen J.Endogenous expression of CD80 co-stimulatory molecule facilitates in vivo tumor regression of oral squamous carcinoma[J].Anticancer Res.2006;26(6B):4093-101.
[33]Sharma S,Chopin K,Kulkami SK,el al.Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway[J].Clin Exp Immunol.2007;147(1):155-63.
[34]Crosby JR,Guha M,Tung D,el al.Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice[J].J Pharmacol Exp Ther.2007;321(3):938-46.
[35]Lee JB,Lee KA,Chang J.Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation[J].Int Immunol.2007;19(9):1039-48..
[36]Hirota T,Suzuki Y,Hasegawa K,el al.Functional haplotypes of IL-12B are associated with childhood atopic asthma[J].J Allergy Clin Immunol.2005;116(4):789-95.
[37]Wu C,Yang G,Bermudez-Humaran LG;el al.Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin(OVA)-induced asthma model mice[J].Int Immunopharmacol.2006;6(4):610-5.
[38]Fu CL,Ye YL,Lee YL,el al.Effects of overexpression of IL-10,IL-12,TGF-beta and IL-4 on allergen induced change in bronchial responsiveness[J].Respir Res.2006;7:72.
[39]Hellings PW,Kasran A,Bullens D,el al.IL-10- and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling[J].J Immunol.2006;177(8):5138-44.
[40]Meyts I,Hellings PW,Hens G,el al.IL-12 contributes to allergen-induced airway inflammation in experimental asthma[J].J Immunol.2006;177(9):6460-70.
[41]Cooper AM,Khader SA.IL-12p40:an inherently agonistic cytokine[J].Trends Immunol.2007;28(1):33-8.
[42]Ando M,Shima M.Serum intedeukins 12 and 18 and immunoglobulin E concentrations and allergic symptoms in Japanese schoolchildren[J].J Investig Allergol Clin Immunol.2007;17(1):14-9.
[43]Sel S,Wegmann M,Sel S,el al.Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10[J].J Immunol.2007;178(12):7805-13.
[44]Isidoro-Garcia M,Davila I,Laffond E,el al.Intedeukin-4(IL4)and Intedeukin-4 receptor (IL4RA)polymorphisms in asthma:a case control study[J].Clin Mol Allergy.2005;3:15.
[45]Kabesch M,Schedel M,Carr D,el al.IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma[J].J Allergy Clin Immunol.2006;117(2):269-74.
[46]Fu CL,Ye YL,Lee YL,el al.Effects of overexpression of IL-10,IL-12,TGF-beta and IL-4 on allergen induced change in bronchial responsiveness[J].Respir Res.2006;7:72.
[47]Kim HA,Heo YJ,Lee SH,el al.No potential role of genetic polymorphisms for IL-4,IL-13 and IL-4 receptor in respiratory allergy:a study in adults working at social welfare facilities in Korea[J].J UOEH.2006 1;28(4):369-79.
[48]Mak JC,Ko FW,Chu CM,el al.Polymorphisms in the IL-4,IL-4 receptor alpha chain,TNF-alpha,and lymphotoxin-alpha genes and risk of asthma in Hong Kong Chinese adults[J].Int Arch Allergy Immunol.2007;144(2):114-22.
[49]Tavakkol Afshari J,Farid Hosseini R,Hosseini Farahabadi S,el al.Association of the Expression of IL-4 and IL-13 Genes,IL-4 and IgE Serum Levels with Allergic Asthma[J].Iran J Allergy Asthma Immunol.2007;6(2):67-72.
[50]Nieuwenhuizen N,Herbert DR,Lopata AL,el al.CD4+ T Cell-Specific Deletion of IL-4Receptor {alpha} Prevents Ovalbumin-Induced Anaphylaxis by an IFN-{gamma}-Dependent Mechanism[J].J Immunol.2007;179(5):2758-65.
[51]Karras JG,Crosby JR,Guha M,el al.Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice[J].Am J Respir Cell Mol Biol.2007;36(3):276-85
[52]Fang SP,Tanaka T,Tago F,el aI.Immunomodulatory effects of gyokuheifusan on INF-gamma/IL-4(l'hl/Th2)balance in ovalbumin(OVA)-induced asthma model mice[J].Biol Pharm Bull.2005;28(5):829-33.
[53]Koch M,Witzenrath M,Reuter C,el al.Role of local pulmonary IFN-gamma expression in murine allergic airway inflammation[J].Am J Respir Cell Mol Biol.2006;35(2):211-9
[54]Kumar RK,Webb DC,Herbert C,el al.Interferon-gamma as a possible target in chronic asthma[J].Inflamm Allergy Drug Targets.2006;5(4):253-6.
[55]Ito I,Laporte JD,Fiset PO,el al.Downregulation of a disintegrin and metalloproteinase 33 by IFN-gamma in human airway smooth muscle cells[J]Am J Respir Cell Mol Biol.2006;35(2):211-9.
[56]Wang G,Liu CT,Wang ZL,Yan CL,el al.Effects of Astragalus membranaceus in promoting T-helper cell type 1 polarization and interferon-gamma production by up-regulating T-bet expression in patients with asthma[J].Chin J Integr Med.2006;12(4):262-7.
[57]Gonzalez-Hernandez Y,Pedraza-Sanchez S,Bland6n-Vijil V,el al.Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma[j].Scand J lmmunol.2007;65(4):368-75.
[58]Wark PA,Bucchied F,Johnston SL,el al.IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations[J].J Allergy Clin Immunol.2007;120(3):586-93.
[59]Meng QR,Gideon KM,Harbo S J,et al.Gene expression profiling in lung tissues from mice exposed to cigarette smoke,lipopolysaccharide,or smoke plus lipopolysaccharide by inhalation[J].Inhal Toxicol.2006;18(8):555-68.
[60]Crume KP,Miller JH,La Flamme AC.Peloruside A,an antimitotic agent,specifically decreases tumor necrosis factor-alpha production by lipopolysaccharide-stimulated murine macrophages[J].Exp Biol Med.2007;232(5):607-13.
[61]del Olmo E,Plaza A,Muro A,et al.Synthesis and evaluation of some lipidic aminoalcohols and diamines as immunomodulators[J].Bioorg Med Chem Lett.2006;16(23):6091-5
[62]Hashimoto M,Asai Y,Tamai R,et al.Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide[J].FEBS Letters,2003;543(1-3):98-102.
[63]Viney JL.Dentritic cell subsets:the ultimate T cell differentiation decision makers[J]? Gut,1999;45(5):640-1.
[64]Horng T,Barton GM,Flavell RA,el al.The adaptor molecule TIRAP provides signaling specificity for Toil-like receptors[J].Nature,2002,;420:329-3.
[65]Casals C,Barrachina M,Serra M,el al.Lipopolysaccharide Up-Regulates MHC Class ⅡExpression on Dendritic Cells through an AP-1 Enhancer without Affecting the Levels of CIITA[J].J Immunol.2007;178(10):6307-15.
[66]den Haan JM,Kraal G,Bevan MJ.Cutting Edge:Lipopolysacchadde Induces IL-10-Producing Regulatory CD4+ T Cells That Suppress the CD8+ T Cell Response[J].J Immunol.2007 May 1;178(9):5429-33.
[1]Edelstein ML,Abedi MR,Wtxon J.Gene therapy clinical trials worldwide to 2007-an update[J].J Gene Med.2007;9(10):833-42.
[2]Kyrkanides S,Kambylafkas P,Miller JH,et al.The cranial base in craniofacial development:a gene therapy study[J].J Dent Res.2007;86(10):956-61.
[3]Muntoni F,Wells D.Genetic treatments in muscular dystrophies[J].Curr Opin Neurol.2007;20(5):590-4.
[4]Kent A,Oosterwijk C.A patient and family perspective on gene therapy for rare diseases[J].J Gene Med.2007;9(10):922-3.
[5]Mulavisala P,Vuylsteke A,Latimer R.Gene therapy in the management of cardiovascular diseases[J].Ann Card Anaesth.2001;4(1):4-6.
[6]Ito MK.ISIS 301012 gene therapy for hypercholesterolemia:sense,antisense,or nonsense?[J]Ann Pharmacother.2007;41(10):1669-78.
[7]Rodino-Klapac LR,Chic0ine LG,Kaspar BK,et al.Gene therapy for duchenne muscular dystrophy:expectations and challenges[J].Arch Neurol.2007;64(9):1236-41.
[8]Tdppel S,Cucchiarini M,Madry H,et al.Gene therapy for articular cartilage repair[J].Proc Inst Mech Eng[H].2007;221(5):451-9.
[9]Kanerva A,Raki M,Hemminki A.Gene therapy of gynaecological diseases[J].Expert Opin Biol Ther.2007;7(9):1347-61.
[10]Mills JN,Dall′era JE,Carlsen SN,et al.Gene therapy for erectile dysfunction[J].Pharmacogenomics.2007;8(8):979-84.
[11]Douglas JT.Adenoviral vectors for gene therapy[J].Mol Biotechnol.2007;36(1):71-80.
[12]Rehman KK,Bertera S,Trucco M,et al.Immunomodulation by adenoviral-mediated SCD40-Ig gene therapy for mouse allogeneic islet transplantation[J]. Transplantation.2007;84(3):301-7.
[13]Lamartina S,Cimino M,Roscilli G,et al.Helper-dependent adenovirus for the gene therapy of proliferative retinopathies:stable gene transfer,regulated gene expression and therapeutic efficacy[J].J Gene Med.2007;9(10):862-74
[14]Xu Y,Darcy PK,Kershaw MH.Tumor-specific dendritic cells generated by genetic redirection of Toll-like receptor signaling against the tumor-associated antigen,erbB2[J].Cancer Gene Ther.2007;14(9):773-80.
[15]Tatsumi T,Takehara T,Yamaguchi S,et al.Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity[J].Gene Ther.2007;14(11):863-71.
[16]Cheng C,Gall JG,Kong WP,et al.Mechanism of ad5 vaccine immunity and toxicity:fiber shaft targeting of dendritic cells[J].PLoS Pathog.2007;3(2):e25.
[17]Tomihara K,Kato K,Masuta Y,et al.Gene transfer of the CD40-1igand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells[J].Int J Cancer.2007;120(7):1491-8.
[18]Bontkes HJ,Kramer D,Ruizendaal JJ,et al.Dendritic cells transfected with intedeukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells[J].Gene Ther.2007;14(4):366-75.
[19]Kyte JA,Gaudemack G.Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells[J].Cancer Immunol Immunother.2006;55(11):1432-42.
[20]Harui A,Roth MD,Vira D,et al.Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of alpha(v)beta3 integrins[J].J Leukoc Biol.2006;79(6):1271-8.
[21]Yang SC,Batra RK,Hillinger S,et al.Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma[J].Cancer Res.2006;66(6):3205-13.
[22]Chinen J,Shearer WT.Advances in basic and clinical immunology in 2006[J].J Allergy Clin Immunol.2007 120(2):263-70..
[23]van Duin D,Shaw AC.Toll-like receptors in older adults.J Am Geriatr Soc.2007;55(9):1438-44.
[24]眭建,许化溪。TLRS与支气管炎症免疫细胞研究进展[J]。中国老年学杂志。2006:26(11):1589-1562
[25]Steinman RM,Hawiger D,Nussenzweig MC.Tolerogenic dendric cells.Annu Rev Immunol 2003;21:685-711
[26]Medzhitov R,Preston HP,Janeway CA.A human homologue cf the Drosophila Toll protein signals activation of adaptive immunity[J].Nature,1997;388(6640):394-7.
[27]Sehra S,Pynaert G,Toumoy K,et al.Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma[J].J Immunol,2003;171(4):2080-9.
[28]Viney JL.Dentritic cell subsets:the ultimate T cell differentiation decision makers[J]? Gut,1999;45(5):640-1.
[29]Homg T,Barton GM,Flavell RA,et al.The adaptor molecule TIRAP provides signaling specificity for Toil-like receptors[J].Nature,2002,;420:329-3.
[30]Horng T,Barlon GM,Medzhitov R.TIRAP:an adaptor molecule in the Toll signaling pathway [J].Nat hnmunol,2001,;2(9):835;41.
[31]Casals C,Barrachina M,Serra M,el al.Lipopolysaccharide Up-Regulates MHC Class ⅡExpression on Dendritic Cells through an AP-1 Enhancer without Affecting the Levels of CI1TA[J].J Immunol.2007;178(10):6307-15.
[32]den Haan JM,Kraal G,Bevan MJ.Cutting Edge:Lipopolysaccharide Induces IL-10-Producing Regulatory CD4+ T Cells That Suppress the CD8+ T Cell Response[J].J Immunol.2007 May 1;178(9):5429-33.
[33]Yamazaki S,Patel M,Harper A,et al.Effective expansion of alloantigen-specific Foxp3+CD25+CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.Proc Natl Acad Sci USA.2006;103(8):2758-2763
[1]Conway JE,Rhys CM,Zolotukhin I,et al.High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap[J].Gene Ther.1999;6(6):986-93.
[2]Miller N,Whelan J.Progress in transcriptionally targeted and regulatable vectors for genetic therapy[J].Hum Gene Ther.1997;8(7):803-15.
[3]Binley K,Iqball S,Kingsman A,et al.An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer[J].Gene Ther.1999;6(10):1721-7.
[4]Wolff JA,Herweijer H.Self-amplifying vectors for gene delivery[J].Adv Drug Deliv Rev.1997;27(1):5-16.
[5]Lieber A,Steinwaerder DS,Carlson CA,et al.Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes[J].J Virol.1999;73(11):9314-24.
[6]Johnston KM,Jacoby D,Pechan PA,et al.HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells[J].Hum Gene Ther.1997;8(3):359-70.
[7]Tan BT,Wu L,Berk AJ.An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency[J].J Virol.1999;73(9):7582-9.
[8]Caplen NJ,Higginbotham JN,Scheel JR,et al.Adeno-retroviral chimeric viruses as in vivo transducing agents[J].Gene Ther.1999;6(3):454-9.
[9]Krasnykh VN,Mikheeva GV,Douglas JT,et al.Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism[J].J Virol.1996;70(10):6839-46.
[10]Mosca PJ,Lyerly HK,Clay TM,et al.Dendritic cell vaccines[J].Front Biosci.2007;12:4050-60.
[11]udewig B,Ochsenbein AF,Odermatt B,et al.Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in sever autoimmune disease[J].J Exp Med,2001,191:795-804.
[12]Eriksson EM,Jackson DC.Recent advances with TLR2-targeting lipopeptide-based vaccines[J].Curr Protein Pept Sci.2007;8(4):412-7.
[13]Chinen J,Shearer WT.Advances in basic and clinical immunology in 2006[J].J Allergy Clin Immunol.2007;120(2):263-70.